id	sid	tid	token	lemma	pos
gra-392	1	1	introduction	introduction	NOUN
gra-392	1	2	dyslipidemia	dyslipidemia	NOUN
gra-392	1	3	is	be	AUX
gra-392	1	4	highly	highly	ADV
gra-392	1	5	prevalent	prevalent	ADJ
gra-392	1	6	in	in	ADP
gra-392	1	7	patients	patient	NOUN
gra-392	1	8	on	on	ADP
gra-392	1	9	maintenance	maintenance	NOUN
gra-392	1	10	hemodialysis	hemodialysis	NOUN
gra-392	1	11	(	(	PUNCT
gra-392	1	12	mhd	mhd	NOUN
gra-392	1	13	)	)	PUNCT
gra-392	1	14	,	,	PUNCT
gra-392	1	15	with	with	ADP
gra-392	1	16	predominance	predominance	NOUN
gra-392	1	17	of	of	ADP
gra-392	1	18	the	the	DET
gra-392	1	19	atherogenic	atherogenic	ADJ
gra-392	1	20	triad	triad	ADJ
gra-392	1	21	,	,	PUNCT
gra-392	1	22	i.e.	i.e.	X
gra-392	1	23	hypertriglyceridemia	hypertriglyceridemia	NOUN
gra-392	1	24	,	,	PUNCT
gra-392	1	25	elevated	elevate	VERB
gra-392	1	26	very	very	ADV
gra-392	1	27	low	low	ADJ
gra-392	1	28	density	density	NOUN
gra-392	1	29	lipoprotein	lipoprotein	ADJ
gra-392	1	30	(	(	PUNCT
gra-392	1	31	vldl	vldl	NOUN
gra-392	1	32	)	)	PUNCT
gra-392	1	33	and	and	CCONJ
gra-392	1	34	reduced	reduce	VERB
gra-392	1	35	high	high	ADJ
gra-392	1	36	-	-	PUNCT
gra-392	1	37	density	density	NOUN
gra-392	1	38	lipoprotein	lipoprotein	ADJ
gra-392	1	39	(	(	PUNCT
gra-392	1	40	hdl	hdl	NOUN
gra-392	1	41	)	)	PUNCT
gra-392	1	42	.	.	PUNCT
gra-392	2	1	the	the	DET
gra-392	2	2	risk	risk	NOUN
gra-392	2	3	factors	factor	NOUN
gra-392	2	4	for	for	ADP
gra-392	2	5	coronary	coronary	ADJ
gra-392	2	6	heart	heart	NOUN
gra-392	2	7	disease	disease	NOUN
gra-392	2	8	(	(	PUNCT
gra-392	2	9	chd	chd	NOUN
gra-392	2	10	)	)	PUNCT
gra-392	2	11	in	in	ADP
gra-392	2	12	the	the	DET
gra-392	2	13	general	general	ADJ
gra-392	2	14	population	population	NOUN
gra-392	2	15	remain	remain	VERB
gra-392	2	16	predictive	predictive	ADJ
gra-392	2	17	of	of	ADP
gra-392	2	18	chd	chd	NOUN
gra-392	2	19	among	among	ADP
gra-392	2	20	patients	patient	NOUN
gra-392	2	21	with	with	ADP
gra-392	2	22	chronic	chronic	ADJ
gra-392	2	23	kidney	kidney	NOUN
gra-392	2	24	disease	disease	NOUN
gra-392	2	25	(	(	PUNCT
gra-392	2	26	ckd	ckd	NOUN
gra-392	2	27	)	)	PUNCT
gra-392	2	28	as	as	ADV
gra-392	2	29	well	well	ADV
gra-392	2	30	.	.	PUNCT
gra-392	3	1	cardiovascular	cardiovascular	ADJ
gra-392	3	2	disease	disease	NOUN
gra-392	3	3	is	be	AUX
gra-392	3	4	the	the	DET
gra-392	3	5	leading	lead	VERB
gra-392	3	6	cause	cause	NOUN
gra-392	3	7	of	of	ADP
gra-392	3	8	death	death	NOUN
gra-392	3	9	in	in	ADP
gra-392	3	10	patients	patient	NOUN
gra-392	3	11	on	on	ADP
gra-392	3	12	mhd	mhd	NOUN
gra-392	3	13	,	,	PUNCT
gra-392	3	14	accounting	account	VERB
gra-392	3	15	for	for	ADP
gra-392	3	16	almost	almost	ADV
gra-392	3	17	50	50	NUM
gra-392	3	18	%	%	NOUN
gra-392	3	19	of	of	ADP
gra-392	3	20	the	the	DET
gra-392	3	21	deaths	death	NOUN
gra-392	3	22	.	.	PUNCT
gra-392	4	1	the	the	DET
gra-392	4	2	incidence	incidence	NOUN
gra-392	4	3	of	of	ADP
gra-392	4	4	cardiac	cardiac	ADJ
gra-392	4	5	death	death	NOUN
gra-392	4	6	in	in	ADP
gra-392	4	7	dialysis	dialysis	NOUN
gra-392	4	8	and	and	CCONJ
gra-392	4	9	transplant	transplant	NOUN
gra-392	4	10	patients	patient	NOUN
gra-392	4	11	has	have	AUX
gra-392	4	12	been	be	AUX
gra-392	4	13	estimated	estimate	VERB
gra-392	4	14	to	to	PART
gra-392	4	15	be	be	AUX
gra-392	4	16	fourto	fourto	VERB
gra-392	4	17	20folds	20folds	NUM
gra-392	4	18	higher	high	ADJ
gra-392	4	19	than	than	ADP
gra-392	4	20	in	in	ADP
gra-392	4	21	the	the	DET
gra-392	4	22	general	general	ADJ
gra-392	4	23	population	population	NOUN
gra-392	4	24	.	.	PUNCT
gra-392	5	1	hyperlipidemia	hyperlipidemia	NOUN
gra-392	5	2	has	have	AUX
gra-392	5	3	been	be	AUX
gra-392	5	4	incriminated	incriminate	VERB
gra-392	5	5	as	as	ADP
gra-392	5	6	a	a	DET
gra-392	5	7	risk	risk	NOUN
gra-392	5	8	factor	factor	NOUN
gra-392	5	9	for	for	ADP
gra-392	5	10	atherosclerotic	atherosclerotic	ADJ
gra-392	5	11	vascular	vascular	ADJ
gra-392	5	12	disease	disease	NOUN
gra-392	5	13	in	in	ADP
gra-392	5	14	dialyzed	dialyzed	ADJ
gra-392	5	15	patients	patient	NOUN
gra-392	5	16	,	,	PUNCT
gra-392	5	17	and	and	CCONJ
gra-392	5	18	is	be	AUX
gra-392	5	19	characterized	characterize	VERB
gra-392	5	20	by	by	ADP
gra-392	5	21	hypertriglyceridemia	hypertriglyceridemia	NOUN
gra-392	5	22	without	without	ADP
gra-392	5	23	cholesterol	cholesterol	NOUN
gra-392	5	24	accumulation	accumulation	NOUN
gra-392	5	25	.	.	PUNCT
gra-392	6	1	other	other	ADJ
gra-392	6	2	dyslipidemias	dyslipidemia	NOUN
gra-392	6	3	consist	consist	VERB
gra-392	6	4	of	of	ADP
gra-392	6	5	decreased	decrease	VERB
gra-392	6	6	hdl	hdl	PROPN
gra-392	6	7	cholesterol	cholesterol	PROPN
gra-392	6	8	and	and	CCONJ
gra-392	6	9	elevated	elevated	ADJ
gra-392	6	10	serum	serum	NOUN
gra-392	6	11	lipoprotein	lipoprotein	NOUN
gra-392	6	12	(	(	PUNCT
gra-392	6	13	lp	lp	NOUN
gra-392	6	14	-	-	PUNCT
gra-392	6	15	a	a	NOUN
gra-392	6	16	)	)	PUNCT
gra-392	6	17	;	;	PUNCT
gra-392	6	18	the	the	DET
gra-392	6	19	low	low	ADJ
gra-392	6	20	-	-	PUNCT
gra-392	6	21	density	density	NOUN
gra-392	6	22	lipoprotein	lipoprotein	ADJ
gra-392	6	23	(	(	PUNCT
gra-392	6	24	ldl	ldl	NOUN
gra-392	6	25	)	)	PUNCT
gra-392	6	26	cholesterol	cholesterol	NOUN
gra-392	6	27	is	be	AUX
gra-392	6	28	usually	usually	ADV
gra-392	6	29	not	not	PART
gra-392	6	30	elevated	elevate	VERB
gra-392	6	31	.	.	PUNCT
gra-392	7	1	lp	lp	ADV
gra-392	7	2	-	-	PUNCT
gra-392	7	3	a	a	NOUN
gra-392	7	4	is	be	AUX
gra-392	7	5	an	an	DET
gra-392	7	6	independent	independent	ADJ
gra-392	7	7	risk	risk	NOUN
gra-392	7	8	factor	factor	NOUN
gra-392	7	9	for	for	ADP
gra-392	7	10	cardiovascular	cardiovascular	ADJ
gra-392	7	11	disease	disease	NOUN
gra-392	7	12	.	.	PUNCT
gra-392	8	1	a	a	DET
gra-392	8	2	number	number	NOUN
gra-392	8	3	of	of	ADP
gra-392	8	4	investigators	investigator	NOUN
gra-392	8	5	have	have	AUX
gra-392	8	6	shown	show	VERB
gra-392	8	7	an	an	DET
gra-392	8	8	increase	increase	NOUN
gra-392	8	9	in	in	ADP
gra-392	8	10	lpa	lpa	PROPN
gra-392	8	11	in	in	ADP
gra-392	8	12	hd	hd	NOUN
gra-392	8	13	patients	patient	NOUN
gra-392	8	14	.	.	PUNCT
gra-392	9	1	cressman	cressman	ADJ
gra-392	9	2	et	et	NOUN
gra-392	9	3	al	al	PROPN
gra-392	9	4	have	have	AUX
gra-392	9	5	suggested	suggest	VERB
gra-392	9	6	that	that	SCONJ
gra-392	9	7	elevated	elevated	ADJ
gra-392	9	8	levels	level	NOUN
gra-392	9	9	of	of	ADP
gra-392	9	10	lipoprotein	lipoprotein	NOUN
gra-392	9	11	also	also	ADV
gra-392	9	12	correlate	correlate	VERB
gra-392	9	13	with	with	ADP
gra-392	9	14	cardiovascular	cardiovascular	ADJ
gra-392	9	15	mortality	mortality	NOUN
gra-392	9	16	.	.	PUNCT
gra-392	10	1	elevated	elevate	VERB
gra-392	10	2	serum	serum	NOUN
gra-392	10	3	magnesium	magnesium	NOUN
gra-392	10	4	(	(	PUNCT
gra-392	10	5	mg	mg	ADJ
gra-392	10	6	)	)	PUNCT
gra-392	10	7	can	can	AUX
gra-392	10	8	be	be	AUX
gra-392	10	9	a	a	DET
gra-392	10	10	problem	problem	NOUN
gra-392	10	11	in	in	ADP
gra-392	10	12	patients	patient	NOUN
gra-392	10	13	on	on	ADP
gra-392	10	14	mhd	mhd	PROPN
gra-392	10	15	.	.	PUNCT
gra-392	11	1	because	because	SCONJ
gra-392	11	2	kidneys	kidney	NOUN
gra-392	11	3	are	be	AUX
gra-392	11	4	the	the	DET
gra-392	11	5	major	major	ADJ
gra-392	11	6	route	route	NOUN
gra-392	11	7	of	of	ADP
gra-392	11	8	excretion	excretion	NOUN
gra-392	11	9	of	of	ADP
gra-392	11	10	mg	mg	PROPN
gra-392	11	11	from	from	ADP
gra-392	11	12	the	the	DET
gra-392	11	13	body	body	NOUN
gra-392	11	14	,	,	PUNCT
gra-392	11	15	increased	increase	VERB
gra-392	11	16	serum	serum	NOUN
gra-392	11	17	mg	mg	PROPN
gra-392	11	18	would	would	AUX
gra-392	11	19	be	be	AUX
gra-392	11	20	expected	expect	VERB
gra-392	11	21	in	in	ADP
gra-392	11	22	patients	patient	NOUN
gra-392	11	23	with	with	ADP
gra-392	11	24	renal	renal	ADJ
gra-392	11	25	insufciency	insufciency	NOUN
gra-392	11	26	.	.	PUNCT
gra-392	12	1	mg	mg	PROPN
gra-392	12	2	may	may	AUX
gra-392	12	3	be	be	AUX
gra-392	12	4	normal	normal	ADJ
gra-392	12	5	or	or	CCONJ
gra-392	12	6	decreased	decrease	VERB
gra-392	12	7	in	in	ADP
gra-392	12	8	dialysis	dialysis	NOUN
gra-392	12	9	patients	patient	NOUN
gra-392	12	10	,	,	PUNCT
gra-392	12	11	which	which	PRON
gra-392	12	12	is	be	AUX
gra-392	12	13	probably	probably	ADV
gra-392	12	14	due	due	ADJ
gra-392	12	15	to	to	PART
gra-392	12	16	decreased	decrease	VERB
gra-392	12	17	dietary	dietary	ADJ
gra-392	12	18	intake	intake	NOUN
gra-392	12	19	combined	combine	VERB
gra-392	12	20	with	with	ADP
gra-392	12	21	impaired	impaired	ADJ
gra-392	12	22	intestinal	intestinal	ADJ
gra-392	12	23	absorption	absorption	NOUN
gra-392	12	24	.	.	PUNCT
gra-392	13	1	in	in	ADP
gra-392	13	2	patients	patient	NOUN
gra-392	13	3	on	on	ADP
gra-392	13	4	chronic	chronic	ADJ
gra-392	13	5	hd	hd	PROPN
gra-392	13	6	,	,	PUNCT
gra-392	13	7	the	the	DET
gra-392	13	8	major	major	ADJ
gra-392	13	9	determinant	determinant	NOUN
gra-392	13	10	of	of	ADP
gra-392	13	11	mg	mg	PROPN
gra-392	13	12	balance	balance	NOUN
gra-392	13	13	is	be	AUX
gra-392	13	14	concentration	concentration	NOUN
gra-392	13	15	of	of	ADP
gra-392	13	16	mg	mg	PROPN
gra-392	13	17	in	in	ADP
gra-392	13	18	the	the	DET
gra-392	13	19	dialysate	dialysate	NOUN
gra-392	13	20	.	.	PUNCT
gra-392	14	1	thus	thus	ADV
gra-392	14	2	,	,	PUNCT
gra-392	14	3	in	in	ADP
gra-392	14	4	patients	patient	NOUN
gra-392	14	5	with	with	ADP
gra-392	14	6	ckd	ckd	PROPN
gra-392	14	7	,	,	PUNCT
gra-392	14	8	there	there	PRON
gra-392	14	9	may	may	AUX
gra-392	14	10	be	be	AUX
gra-392	14	11	reduced	reduce	VERB
gra-392	14	12	intake	intake	ADJ
gra-392	14	13	,	,	PUNCT
gra-392	14	14	impaired	impaired	ADJ
gra-392	14	15	absorption	absorption	NOUN
gra-392	14	16	from	from	ADP
gra-392	14	17	the	the	DET
gra-392	14	18	intestine	intestine	NOUN
gra-392	14	19	,	,	PUNCT
gra-392	14	20	use	use	NOUN
gra-392	14	21	of	of	ADP
gra-392	14	22	diuretics	diuretic	NOUN
gra-392	14	23	and	and	CCONJ
gra-392	14	24	acidosis	acidosis	NOUN
gra-392	14	25	,	,	PUNCT
gra-392	14	26	which	which	PRON
gra-392	14	27	may	may	AUX
gra-392	14	28	result	result	VERB
gra-392	14	29	in	in	ADP
gra-392	14	30	decreased	decrease	VERB
gra-392	14	31	serum	serum	NOUN
gra-392	14	32	mg	mg	PROPN
gra-392	14	33	,	,	PUNCT
gra-392	14	34	wher	wher	VERB
gra-392	14	35	as	as	SCONJ
gra-392	14	36	reduced	reduce	VERB
gra-392	14	37	renal	renal	ADJ
gra-392	14	38	excretion	excretion	NOUN
gra-392	14	39	may	may	AUX
gra-392	14	40	cause	cause	VERB
gra-392	14	41	accumulation	accumulation	NOUN
gra-392	14	42	of	of	ADP
gra-392	14	43	mg	mg	PROPN
gra-392	14	44	resulting	result	VERB
gra-392	14	45	in	in	ADP
gra-392	14	46	increased	increase	VERB
gra-392	14	47	serum	serum	NOUN
gra-392	14	48	mg	mg	PROPN
gra-392	14	49	levels	level	NOUN
gra-392	14	50	in	in	ADP
gra-392	14	51	ckd	ckd	PROPN
gra-392	14	52	patients	patient	NOUN
gra-392	14	53	.	.	PUNCT
gra-392	15	1	bone	bone	NOUN
gra-392	15	2	concentration	concentration	NOUN
gra-392	15	3	and	and	CCONJ
gra-392	15	4	total	total	ADJ
gra-392	15	5	body	body	NOUN
gra-392	15	6	mg	mg	PRON
gra-392	15	7	also	also	ADV
gra-392	15	8	appear	appear	VERB
gra-392	15	9	to	to	PART
gra-392	15	10	be	be	AUX
gra-392	15	11	increased	increase	VERB
gra-392	15	12	.	.	PUNCT
gra-392	16	1	data	datum	NOUN
gra-392	16	2	have	have	AUX
gra-392	16	3	shown	show	VERB
gra-392	16	4	a	a	DET
gra-392	16	5	correlation	correlation	NOUN
gra-392	16	6	between	between	ADP
gra-392	16	7	dyslipidemia	dyslipidemia	NOUN
gra-392	16	8	and	and	CCONJ
gra-392	16	9	serum	serum	VERB
gra-392	16	10	mg	mg	PROPN
gra-392	16	11	concentration	concentration	NOUN
gra-392	16	12	in	in	ADP
gra-392	16	13	patients	patient	NOUN
gra-392	16	14	on	on	ADP
gra-392	16	15	hd	hd	PROPN
gra-392	16	16	.	.	PUNCT
gra-392	17	1	therefore	therefore	ADV
gra-392	17	2	,	,	PUNCT
gra-392	17	3	we	we	PRON
gra-392	17	4	designed	design	VERB
gra-392	17	5	this	this	DET
gra-392	17	6	study	study	NOUN
gra-392	17	7	to	to	PART
gra-392	17	8	assess	assess	VERB
gra-392	17	9	the	the	DET
gra-392	17	10	association	association	NOUN
gra-392	17	11	between	between	ADP
gra-392	17	12	serum	serum	NOUN
gra-392	17	13	mg	mg	PROPN
gra-392	17	14	and	and	CCONJ
gra-392	17	15	dyslipidemia	dyslipidemia	VERB
gra-392	17	16	in	in	ADP
gra-392	17	17	patients	patient	NOUN
gra-392	17	18	on	on	ADP
gra-392	17	19	endstage	endstage	NOUN
gra-392	17	20	renal	renal	ADJ
gra-392	17	21	disease	disease	NOUN
gra-392	17	22	patients	patient	NOUN
gra-392	17	23	and	and	CCONJ
gra-392	17	24	methods	method	NOUN
gra-392	17	25	:	:	PUNCT
gra-392	17	26	fifty	fifty	NUM
gra-392	17	27	patients	patient	NOUN
gra-392	17	28	with	with	ADP
gra-392	17	29	diagnosis	diagnosis	NOUN
gra-392	17	30	of	of	ADP
gra-392	17	31	chronic	chronic	ADJ
gra-392	17	32	kidney	kidney	NOUN
gra-392	17	33	disease	disease	NOUN
gra-392	17	34	who	who	PRON
gra-392	17	35	are	be	AUX
gra-392	17	36	on	on	ADP
gra-392	17	37	routine	routine	ADJ
gra-392	17	38	dialysis	dialysis	NOUN
gra-392	17	39	for	for	ADP
gra-392	17	40	more	more	ADJ
gra-392	17	41	than	than	ADP
gra-392	17	42	3	3	NUM
gra-392	17	43	months	month	NOUN
gra-392	17	44	admitted	admit	VERB
gra-392	17	45	to	to	ADP
gra-392	17	46	medicine	medicine	PROPN
gra-392	17	47	department	department	PROPN
gra-392	17	48	of	of	ADP
gra-392	17	49	sree	sree	PROPN
gra-392	17	50	balaji	balaji	PROPN
gra-392	17	51	medical	medical	PROPN
gra-392	17	52	college	college	PROPN
gra-392	17	53	,	,	PUNCT
gra-392	17	54	chennai	chennai	PROPN
gra-392	17	55	were	be	AUX
gra-392	17	56	taken	take	VERB
gra-392	17	57	for	for	ADP
gra-392	17	58	the	the	DET
gra-392	17	59	study	study	NOUN
gra-392	17	60	.	.	PUNCT
gra-392	18	1	the	the	DET
gra-392	18	2	patient	patient	NOUN
gra-392	18	3	excluded	exclude	VERB
gra-392	18	4	were	be	AUX
gra-392	18	5	patient	patient	ADJ
gra-392	18	6	having	have	VERB
gra-392	18	7	acute	acute	ADJ
gra-392	18	8	renal	renal	ADJ
gra-392	18	9	failure	failure	NOUN
gra-392	18	10	,	,	PUNCT
gra-392	18	11	history	history	NOUN
gra-392	18	12	of	of	ADP
gra-392	18	13	carotid	carotid	NOUN
gra-392	18	14	surgery	surgery	NOUN
gra-392	18	15	,	,	PUNCT
gra-392	18	16	malignancy	malignancy	NOUN
gra-392	18	17	;	;	PUNCT
gra-392	18	18	signicant	signicant	ADJ
gra-392	18	19	illness	illness	NOUN
gra-392	18	20	and	and	CCONJ
gra-392	18	21	patients	patient	NOUN
gra-392	18	22	on	on	ADP
gra-392	18	23	magnesium	magnesium	NOUN
gra-392	18	24	therapy	therapy	NOUN
gra-392	18	25	.	.	PUNCT
gra-392	19	1	information	information	NOUN
gra-392	19	2	was	be	AUX
gra-392	19	3	collected	collect	VERB
gra-392	19	4	through	through	ADP
gra-392	19	5	prepared	prepared	ADJ
gra-392	19	6	proforma	proforma	NOUN
gra-392	19	7	for	for	ADP
gra-392	19	8	each	each	DET
gra-392	19	9	patient	patient	NOUN
gra-392	19	10	and	and	CCONJ
gra-392	19	11	informed	informed	ADJ
gra-392	19	12	consent	consent	NOUN
gra-392	19	13	was	be	AUX
gra-392	19	14	obtained	obtain	VERB
gra-392	19	15	from	from	ADP
gra-392	19	16	each	each	DET
gra-392	19	17	participant	participant	NOUN
gra-392	19	18	.	.	PUNCT
gra-392	20	1	history	history	NOUN
gra-392	20	2	of	of	ADP
gra-392	20	3	smoking	smoking	NOUN
gra-392	20	4	,	,	PUNCT
gra-392	20	5	dm	dm	NOUN
gra-392	20	6	,	,	PUNCT
gra-392	20	7	hypertension	hypertension	NOUN
gra-392	20	8	.	.	PUNCT
gra-392	21	1	cardiovascular	cardiovascular	ADJ
gra-392	21	2	event	event	NOUN
gra-392	21	3	,	,	PUNCT
gra-392	21	4	hyperlipidemia	hyperlipidemia	NOUN
gra-392	21	5	and	and	CCONJ
gra-392	21	6	use	use	NOUN
gra-392	21	7	of	of	ADP
gra-392	21	8	statin	statin	ADJ
gra-392	21	9	and	and	CCONJ
gra-392	21	10	magnesium	magnesium	NOUN
gra-392	21	11	therapy	therapy	NOUN
gra-392	21	12	were	be	AUX
gra-392	21	13	evaluated	evaluate	VERB
gra-392	21	14	.	.	PUNCT
gra-392	22	1	a	a	DET
gra-392	22	2	complete	complete	ADJ
gra-392	22	3	clinical	clinical	ADJ
gra-392	22	4	examination	examination	NOUN
gra-392	22	5	was	be	AUX
gra-392	22	6	done	do	VERB
gra-392	22	7	with	with	ADP
gra-392	22	8	special	special	ADJ
gra-392	22	9	reference	reference	NOUN
gra-392	22	10	to	to	ADP
gra-392	22	11	signs	sign	NOUN
gra-392	22	12	of	of	ADP
gra-392	22	13	ckd	ckd	PROPN
gra-392	22	14	like	like	ADP
gra-392	22	15	pallor	pallor	NOUN
gra-392	22	16	,	,	PUNCT
gra-392	22	17	pufness	pufness	NOUN
gra-392	22	18	of	of	ADP
gra-392	22	19	face	face	NOUN
gra-392	22	20	etc	etc	X
gra-392	22	21	.	.	PUNCT
gra-392	23	1	blood	blood	NOUN
gra-392	23	2	pressure	pressure	NOUN
gra-392	23	3	was	be	AUX
gra-392	23	4	measured	measure	VERB
gra-392	23	5	with	with	ADP
gra-392	23	6	standard	standard	ADJ
gra-392	23	7	mercury	mercury	NOUN
gra-392	23	8	sphygmomanometer	sphygmomanometer	NOUN
gra-392	23	9	and	and	CCONJ
gra-392	23	10	cuff	cuff	NOUN
gra-392	23	11	,	,	PUNCT
gra-392	23	12	after	after	SCONJ
gra-392	23	13	the	the	DET
gra-392	23	14	subject	subject	NOUN
gra-392	23	15	had	have	AUX
gra-392	23	16	rested	rest	VERB
gra-392	23	17	in	in	ADP
gra-392	23	18	supine	supine	ADJ
gra-392	23	19	position	position	NOUN
gra-392	23	20	for	for	ADP
gra-392	23	21	15	15	NUM
gra-392	23	22	minutes	minute	NOUN
gra-392	23	23	..	..	PUNCT
gra-392	23	24	hypertension	hypertension	NOUN
gra-392	23	25	was	be	AUX
gra-392	23	26	dened	dene	VERB
gra-392	23	27	as	as	ADP
gra-392	23	28	blood	blood	NOUN
gra-392	23	29	pressure	pressure	NOUN
gra-392	23	30	>	>	X
gra-392	23	31	140/90	140/90	NUM
gra-392	23	32	mm	mm	NOUN
gra-392	23	33	hg	hg	NOUN
gra-392	24	1	or	or	CCONJ
gra-392	24	2	if	if	SCONJ
gra-392	24	3	patient	patient	ADJ
gra-392	24	4	is	be	AUX
gra-392	24	5	already	already	ADV
gra-392	24	6	on	on	ADP
gra-392	24	7	antihypertensive	antihypertensive	ADJ
gra-392	24	8	drug	drug	NOUN
gra-392	24	9	.	.	PUNCT
gra-392	25	1	the	the	DET
gra-392	25	2	morning	morning	NOUN
gra-392	25	3	urine	urine	NOUN
gra-392	25	4	sample	sample	NOUN
gra-392	25	5	and	and	CCONJ
gra-392	25	6	blood	blood	NOUN
gra-392	25	7	samples	sample	NOUN
gra-392	25	8	were	be	AUX
gra-392	25	9	collected	collect	VERB
gra-392	25	10	after	after	ADP
gra-392	25	11	8	8	NUM
gra-392	25	12	hours	hour	NOUN
gra-392	25	13	of	of	ADP
gra-392	25	14	overnight	overnight	ADJ
gra-392	25	15	fasting	fast	VERB
gra-392	25	16	for	for	ADP
gra-392	25	17	complete	complete	ADJ
gra-392	25	18	hemogram	hemogram	NOUN
gra-392	25	19	,	,	PUNCT
gra-392	25	20	blood	blood	NOUN
gra-392	25	21	urea	urea	NOUN
gra-392	25	22	levels	level	NOUN
gra-392	25	23	,	,	PUNCT
gra-392	25	24	serum	serum	NOUN
gra-392	25	25	creatinine	creatinine	NOUN
gra-392	25	26	levels	level	NOUN
gra-392	25	27	,	,	PUNCT
gra-392	25	28	serum	serum	NOUN
gra-392	25	29	elecrolytes	elecrolyte	NOUN
gra-392	25	30	and	and	CCONJ
gra-392	25	31	lipid	lipid	NOUN
gra-392	25	32	prole	prole	PROPN
gra-392	25	33	(	(	PUNCT
gra-392	25	34	total	total	ADJ
gra-392	25	35	cholesterol	cholesterol	NOUN
gra-392	25	36	,	,	PUNCT
gra-392	25	37	triglycerides	triglyceride	NOUN
gra-392	25	38	and	and	CCONJ
gra-392	25	39	hdl	hdl	NOUN
gra-392	25	40	)	)	PUNCT
gra-392	25	41	and	and	CCONJ
gra-392	25	42	serum	serum	NOUN
gra-392	25	43	magnesium	magnesium	NOUN
gra-392	25	44	.	.	PUNCT
gra-392	26	1	all	all	DET
gra-392	26	2	the	the	DET
gra-392	26	3	biochemical	biochemical	ADJ
gra-392	26	4	parameters	parameter	NOUN
gra-392	26	5	were	be	AUX
gra-392	26	6	measured	measure	VERB
gra-392	26	7	by	by	ADP
gra-392	26	8	standard	standard	ADJ
gra-392	26	9	laboratory	laboratory	NOUN
gra-392	26	10	technique	technique	NOUN
gra-392	26	11	..	..	PUNCT
gra-392	26	12	glomerular	glomerular	ADJ
gra-392	26	13	ltration	ltration	NOUN
gra-392	26	14	rate	rate	NOUN
gra-392	26	15	(	(	PUNCT
gra-392	26	16	gfr	gfr	NOUN
gra-392	26	17	)	)	PUNCT
gra-392	26	18	was	be	AUX
gra-392	26	19	calculated	calculate	VERB
gra-392	26	20	by	by	ADP
gra-392	26	21	cockcroft	cockcroft	PROPN
gra-392	26	22	gault	gault	PROPN
gra-392	26	23	equation	equation	PROPN
gra-392	26	24	.	.	PUNCT
gra-392	27	1	dialysis	dialysis	NOUN
gra-392	27	2	was	be	AUX
gra-392	27	3	performed	perform	VERB
gra-392	27	4	using	use	VERB
gra-392	27	5	dialog	dialog	NOUN
gra-392	27	6	+	+	CCONJ
gra-392	27	7	dialysis	dialysis	NOUN
gra-392	27	8	machine	machine	NOUN
gra-392	27	9	with	with	ADP
gra-392	27	10	ultraltration	ultraltration	PROPN
gra-392	27	11	rate	rate	NOUN
gra-392	27	12	from	from	ADP
gra-392	27	13	500	500	NUM
gra-392	27	14	to	to	PART
gra-392	27	15	800	800	NUM
gra-392	27	16	mt	mt	PROPN
gra-392	27	17	/	/	SYM
gra-392	27	18	hr	hr	NOUN
gra-392	27	19	and	and	CCONJ
gra-392	27	20	temperature	temperature	NOUN
gra-392	27	21	of	of	ADP
gra-392	27	22	diasylate	diasylate	NOUN
gra-392	27	23	to	to	ADP
gra-392	27	24	he	he	PRON
gra-392	27	25	maintained	maintain	VERB
gra-392	27	26	at	at	ADP
gra-392	27	27	36.5	36.5	NUM
gra-392	27	28	0	0	NUM
gra-392	27	29	c.	c.	NOUN
gra-392	27	30	the	the	DET
gra-392	27	31	diasylate	diasylate	NOUN
gra-392	27	32	solution	solution	NOUN
gra-392	27	33	used	use	VERB
gra-392	27	34	was	be	AUX
gra-392	27	35	as	as	SCONJ
gra-392	27	36	follows	follow	VERB
gra-392	27	37	:	:	PUNCT
gra-392	27	38	sodium	sodium	NOUN
gra-392	27	39	7900	7900	NUM
gra-392	27	40	mmol	mmol	NOUN
gra-392	27	41	/	/	SYM
gra-392	27	42	l	l	NOUN
gra-392	27	43	,	,	PUNCT
gra-392	27	44	pottasium	pottasium	NOUN
gra-392	27	45	2.00	2.00	NUM
gra-392	27	46	mmol	mmol	NOUN
gra-392	27	47	/	/	SYM
gra-392	27	48	l	l	NOUN
gra-392	27	49	,	,	PUNCT
gra-392	27	50	calcium	calcium	NOUN
gra-392	27	51	1.7smrnol	1.7smrnol	NUM
gra-392	27	52	/	/	SYM
gra-392	27	53	l	l	NOUN
gra-392	27	54	,	,	PUNCT
gra-392	27	55	magnesium	magnesium	NOUN
gra-392	27	56	0.75	0.75	NUM
gra-392	27	57	mmol	mmol	NOUN
gra-392	27	58	/	/	SYM
gra-392	27	59	l	l	NOUN
gra-392	27	60	,	,	PUNCT
gra-392	28	1	acetate	acetate	NOUN
gra-392	28	2	4.0	4.0	NUM
gra-392	28	3	mmol	mmol	NOUN
gra-392	28	4	/	/	SYM
gra-392	28	5	l	l	NOUN
gra-392	28	6	and	and	CCONJ
gra-392	28	7	chloride	chloride	NOUN
gra-392	28	8	86.0	86.0	NUM
gra-392	28	9	mmol	mmol	NOUN
gra-392	28	10	/	/	SYM
gra-392	28	11	l.	l.	NOUN
gra-392	29	1	a	a	DET
gra-392	29	2	study	study	NOUN
gra-392	29	3	on	on	ADP
gra-392	29	4	correlation	correlation	NOUN
gra-392	29	5	of	of	ADP
gra-392	29	6	serum	serum	NOUN
gra-392	29	7	magnesium	magnesium	NOUN
gra-392	29	8	with	with	ADP
gra-392	29	9	lipid	lipid	NOUN
gra-392	29	10	profile	profile	NOUN
gra-392	29	11	in	in	ADP
gra-392	29	12	ckd	ckd	PROPN
gra-392	29	13	patients	patient	NOUN
gra-392	29	14	on	on	ADP
gra-392	29	15	maintenance	maintenance	NOUN
gra-392	29	16	hemodialysis	hemodialysis	NOUN
gra-392	29	17	original	original	ADJ
gra-392	29	18	research	research	NOUN
gra-392	29	19	paper	paper	PROPN
gra-392	29	20	dr	dr	PROPN
gra-392	29	21	.	.	PROPN
gra-392	29	22	venkat	venkat	PROPN
gra-392	29	23	sai	sai	PROPN
gra-392	29	24	.	.	PUNCT
gra-392	29	25	gangapatnam	gangapatnam	PROPN
gra-392	29	26	*	*	PUNCT
gra-392	29	27	junior	junior	ADJ
gra-392	29	28	resident	resident	ADJ
gra-392	29	29	department	department	PROPN
gra-392	29	30	of	of	ADP
gra-392	29	31	general	general	ADJ
gra-392	29	32	medicine	medicine	NOUN
gra-392	29	33	,	,	PUNCT
gra-392	29	34	sree	sree	PROPN
gra-392	29	35	balaji	balaji	PROPN
gra-392	29	36	medical	medical	PROPN
gra-392	29	37	college	college	PROPN
gra-392	29	38	,	,	PUNCT
gra-392	29	39	chennai	chennai	PROPN
gra-392	29	40	,	,	PUNCT
gra-392	29	41	tamil	tamil	PROPN
gra-392	29	42	nadu	nadu	NOUN
gra-392	29	43	*	*	PUNCT
gra-392	29	44	corresponding	correspond	VERB
gra-392	29	45	author	author	NOUN
gra-392	29	46	general	general	PROPN
gra-392	29	47	medicine	medicine	PROPN
gra-392	29	48	objective	objective	NOUN
gra-392	29	49	:	:	PUNCT
gra-392	29	50	the	the	DET
gra-392	29	51	objective	objective	NOUN
gra-392	29	52	this	this	DET
gra-392	29	53	study	study	NOUN
gra-392	29	54	was	be	AUX
gra-392	29	55	performed	perform	VERB
gra-392	29	56	to	to	PART
gra-392	29	57	determine	determine	VERB
gra-392	29	58	the	the	DET
gra-392	29	59	correlation	correlation	NOUN
gra-392	29	60	between	between	ADP
gra-392	29	61	serum	serum	NOUN
gra-392	29	62	magnesium	magnesium	NOUN
gra-392	29	63	(	(	PUNCT
gra-392	29	64	mg	mg	PROPN
gra-392	29	65	)	)	PUNCT
gra-392	29	66	and	and	CCONJ
gra-392	29	67	lipid	lipid	NOUN
gra-392	29	68	prole	prole	PROPN
gra-392	29	69	in	in	ADP
gra-392	29	70	patients	patient	NOUN
gra-392	29	71	on	on	ADP
gra-392	29	72	maintenance	maintenance	NOUN
gra-392	29	73	hemodialysis	hemodialysis	NOUN
gra-392	29	74	(	(	PUNCT
gra-392	29	75	mhd	mhd	NOUN
gra-392	29	76	)	)	PUNCT
gra-392	29	77	.	.	PUNCT
gra-392	30	1	material	material	PROPN
gra-392	30	2	&	&	CCONJ
gra-392	30	3	method	method	PROPN
gra-392	30	4	:	:	PUNCT
gra-392	30	5	this	this	DET
gra-392	30	6	hospital	hospital	NOUN
gra-392	30	7	-	-	PUNCT
gra-392	30	8	based	base	VERB
gra-392	30	9	crosssectional	crosssectional	ADJ
gra-392	30	10	observational	observational	ADJ
gra-392	30	11	study	study	NOUN
gra-392	30	12	was	be	AUX
gra-392	30	13	conducted	conduct	VERB
gra-392	30	14	at	at	ADP
gra-392	30	15	the	the	DET
gra-392	30	16	department	department	NOUN
gra-392	30	17	of	of	ADP
gra-392	30	18	medicine	medicine	NOUN
gra-392	30	19	,	,	PUNCT
gra-392	30	20	sree	sree	PROPN
gra-392	30	21	balaji	balaji	PROPN
gra-392	30	22	medical	medical	PROPN
gra-392	30	23	college	college	PROPN
gra-392	30	24	,	,	PUNCT
gra-392	30	25	chennai	chennai	NOUN
gra-392	30	26	.	.	PUNCT
gra-392	31	1	fifty	fifty	NUM
gra-392	31	2	patients	patient	NOUN
gra-392	31	3	with	with	ADP
gra-392	31	4	end	end	NOUN
gra-392	31	5	-	-	PUNCT
gra-392	31	6	stage	stage	NOUN
gra-392	31	7	kidney	kidney	NOUN
gra-392	31	8	disease	disease	NOUN
gra-392	31	9	on	on	ADP
gra-392	31	10	mhd	mhd	PROPN
gra-392	31	11	treatment	treatment	NOUN
gra-392	31	12	(	(	PUNCT
gra-392	31	13	29	29	NUM
gra-392	31	14	males	male	NOUN
gra-392	31	15	and	and	CCONJ
gra-392	31	16	21	21	NUM
gra-392	31	17	females	female	NOUN
gra-392	31	18	)	)	PUNCT
gra-392	31	19	were	be	AUX
gra-392	31	20	studied	study	VERB
gra-392	31	21	.	.	PUNCT
gra-392	32	1	the	the	DET
gra-392	32	2	mean	mean	ADJ
gra-392	32	3	frequency	frequency	NOUN
gra-392	32	4	being	be	AUX
gra-392	32	5	two	two	NUM
gra-392	32	6	to	to	PART
gra-392	32	7	three	three	NUM
gra-392	32	8	sessions	session	NOUN
gra-392	32	9	/week	/week	PUNCT
gra-392	32	10	of	of	ADP
gra-392	32	11	hemodialysis	hemodialysis	NOUN
gra-392	32	12	and	and	CCONJ
gra-392	32	13	each	each	DET
gra-392	32	14	session	session	NOUN
gra-392	32	15	lasted	last	VERB
gra-392	32	16	for	for	ADP
gra-392	32	17	four	four	NUM
gra-392	32	18	hours	hour	NOUN
gra-392	32	19	.	.	PUNCT
gra-392	33	1	after	after	ADP
gra-392	33	2	obtaining	obtain	VERB
gra-392	33	3	informed	informed	ADJ
gra-392	33	4	written	write	VERB
gra-392	33	5	consent	consent	NOUN
gra-392	33	6	,	,	PUNCT
gra-392	33	7	the	the	DET
gra-392	33	8	general	general	ADJ
gra-392	33	9	information	information	NOUN
gra-392	33	10	of	of	ADP
gra-392	33	11	each	each	DET
gra-392	33	12	patient	patient	NOUN
gra-392	33	13	was	be	AUX
gra-392	33	14	recorded	record	VERB
gra-392	33	15	on	on	ADP
gra-392	33	16	a	a	DET
gra-392	33	17	proforma	proforma	NOUN
gra-392	33	18	.	.	PUNCT
gra-392	34	1	after	after	ADP
gra-392	34	2	overnight	overnight	ADJ
gra-392	34	3	fasting	fasting	NOUN
gra-392	34	4	,	,	PUNCT
gra-392	34	5	blood	blood	NOUN
gra-392	34	6	samples	sample	NOUN
gra-392	34	7	was	be	AUX
gra-392	34	8	drawn	draw	VERB
gra-392	34	9	for	for	ADP
gra-392	34	10	complete	complete	ADJ
gra-392	34	11	hemogram	hemogram	PROPN
gra-392	34	12	,	,	PUNCT
gra-392	34	13	blood	blood	NOUN
gra-392	34	14	urea	urea	NOUN
gra-392	34	15	,	,	PUNCT
gra-392	34	16	serum	serum	NOUN
gra-392	34	17	creatinine	creatinine	NOUN
gra-392	34	18	,	,	PUNCT
gra-392	34	19	lipid	lipid	NOUN
gra-392	34	20	prole	prole	PROPN
gra-392	34	21	and	and	CCONJ
gra-392	34	22	serum	serum	NOUN
gra-392	34	23	mg	mg	PROPN
gra-392	34	24	.	.	PUNCT
gra-392	35	1	results	result	NOUN
gra-392	35	2	:	:	PUNCT
gra-392	35	3	the	the	DET
gra-392	35	4	serum	serum	NOUN
gra-392	35	5	magnesium	magnesium	NOUN
gra-392	35	6	was	be	AUX
gra-392	35	7	signicantly	signicantly	ADV
gra-392	35	8	correlated	correlate	VERB
gra-392	35	9	with	with	ADP
gra-392	35	10	diabetes	diabetes	NOUN
gra-392	35	11	in	in	ADP
gra-392	35	12	the	the	DET
gra-392	35	13	study	study	NOUN
gra-392	35	14	.	.	PUNCT
gra-392	36	1	(	(	PUNCT
gra-392	36	2	p	p	X
gra-392	36	3	<	<	X
gra-392	36	4	0.001	0.001	NUM
gra-392	36	5	)	)	PUNCT
gra-392	36	6	the	the	DET
gra-392	36	7	mean	mean	ADJ
gra-392	36	8	bmi	bmi	NOUN
gra-392	36	9	in	in	ADP
gra-392	36	10	ckd	ckd	PROPN
gra-392	36	11	patients	patient	NOUN
gra-392	36	12	was	be	AUX
gra-392	36	13	18.37	18.37	NUM
gra-392	36	14	±	±	NUM
gra-392	36	15	1.82	1.82	NUM
gra-392	36	16	kg	kg	NOUN
gra-392	36	17	/	/	SYM
gra-392	36	18	m2	m2	PROPN
gra-392	36	19	in	in	ADP
gra-392	36	20	the	the	DET
gra-392	36	21	present	present	ADJ
gra-392	36	22	study	study	NOUN
gra-392	36	23	most	most	ADJ
gra-392	36	24	of	of	ADP
gra-392	36	25	the	the	DET
gra-392	36	26	ckd	ckd	PROPN
gra-392	36	27	patients	patient	NOUN
gra-392	36	28	was	be	AUX
gra-392	36	29	in	in	ADP
gra-392	36	30	stage	stage	NOUN
gra-392	36	31	5	5	NUM
gra-392	36	32	.	.	PUNCT
gra-392	36	33	i.e.	i.e.	X
gra-392	36	34	43	43	NUM
gra-392	36	35	cases	case	NOUN
gra-392	36	36	.	.	PUNCT
gra-392	37	1	total	total	ADJ
gra-392	37	2	serum	serum	NOUN
gra-392	37	3	cholesterol	cholesterol	NOUN
gra-392	37	4	levels	level	NOUN
gra-392	37	5	(	(	PUNCT
gra-392	37	6	>	>	SYM
gra-392	37	7	200	200	NUM
gra-392	37	8	mg	mg	PROPN
gra-392	37	9	/	/	SYM
gra-392	37	10	dl	dl	PROPN
gra-392	37	11	)	)	PUNCT
gra-392	37	12	was	be	AUX
gra-392	37	13	found	find	VERB
gra-392	37	14	higher	high	ADJ
gra-392	37	15	than	than	ADP
gra-392	37	16	normal	normal	ADJ
gra-392	37	17	in	in	ADP
gra-392	37	18	15	15	NUM
gra-392	37	19	cases	case	NOUN
gra-392	37	20	and	and	CCONJ
gra-392	37	21	the	the	DET
gra-392	37	22	mean	mean	NOUN
gra-392	37	23	was	be	AUX
gra-392	37	24	174.1	174.1	NUM
gra-392	37	25	±	±	NUM
gra-392	37	26	44.62	44.62	NUM
gra-392	37	27	.	.	PUNCT
gra-392	38	1	the	the	DET
gra-392	38	2	mean	mean	ADJ
gra-392	38	3	serum	serum	NOUN
gra-392	38	4	triglyceride	triglyceride	PROPN
gra-392	38	5	levels	level	NOUN
gra-392	38	6	was	be	AUX
gra-392	38	7	144.54	144.54	NUM
gra-392	38	8	±	±	NUM
gra-392	38	9	58.09	58.09	NUM
gra-392	38	10	mg/	mg/	NOUN
gra-392	38	11	dl	dl	PROPN
gra-392	38	12	in	in	ADP
gra-392	38	13	ckd	ckd	PROPN
gra-392	38	14	patients	patient	NOUN
gra-392	38	15	and	and	CCONJ
gra-392	38	16	it	it	PRON
gra-392	38	17	correlated	correlate	VERB
gra-392	38	18	signicantly	signicantly	ADV
gra-392	38	19	with	with	ADP
gra-392	38	20	serum	serum	NOUN
gra-392	38	21	magnesium	magnesium	NOUN
gra-392	38	22	.	.	PUNCT
gra-392	39	1	the	the	DET
gra-392	39	2	mean	mean	ADJ
gra-392	39	3	hdl	hdl	PROPN
gra-392	39	4	-	-	PUNCT
gra-392	39	5	c	c	PROPN
gra-392	39	6	levels	level	NOUN
gra-392	39	7	was	be	AUX
gra-392	39	8	39.26	39.26	NUM
gra-392	39	9	±	±	NUM
gra-392	39	10	6.40	6.40	NUM
gra-392	39	11	mg	mg	PROPN
gra-392	39	12	/	/	SYM
gra-392	39	13	dl	dl	PROPN
gra-392	39	14	were	be	AUX
gra-392	39	15	lower	low	ADJ
gra-392	39	16	in	in	SCONJ
gra-392	39	17	ckd	ckd	PROPN
gra-392	39	18	patients	patient	NOUN
gra-392	39	19	found	find	VERB
gra-392	39	20	.	.	PUNCT
gra-392	40	1	in	in	ADP
gra-392	40	2	30	30	NUM
gra-392	40	3	patients	patient	NOUN
gra-392	40	4	among	among	ADP
gra-392	40	5	50	50	NUM
gra-392	40	6	cases	case	NOUN
gra-392	40	7	.	.	PUNCT
gra-392	41	1	serum	serum	NOUN
gra-392	41	2	magnesium	magnesium	NOUN
gra-392	41	3	in	in	ADP
gra-392	41	4	ckd	ckd	PROPN
gra-392	41	5	patients	patient	NOUN
gra-392	41	6	signicantly	signicantly	ADV
gra-392	41	7	correlated	correlate	VERB
gra-392	41	8	with	with	ADP
gra-392	41	9	age	age	NOUN
gra-392	41	10	(	(	PUNCT
gra-392	41	11	p	p	X
gra-392	41	12	<	<	X
gra-392	41	13	0.001	0.001	NUM
gra-392	41	14	)	)	PUNCT
gra-392	41	15	,	,	PUNCT
gra-392	41	16	systolic	systolic	ADJ
gra-392	41	17	blood	blood	NOUN
gra-392	41	18	pressure	pressure	NOUN
gra-392	41	19	(	(	PUNCT
gra-392	41	20	p<0.001	p<0.001	PROPN
gra-392	41	21	)	)	PUNCT
gra-392	41	22	,	,	PUNCT
gra-392	41	23	serum	serum	NOUN
gra-392	41	24	triglyceride	triglyceride	PROPN
gra-392	41	25	levels	level	NOUN
gra-392	41	26	(	(	PUNCT
gra-392	41	27	p=0.02	p=0.02	NOUN
gra-392	41	28	)	)	PUNCT
gra-392	41	29	,	,	PUNCT
gra-392	41	30	the	the	DET
gra-392	41	31	mean	mean	ADJ
gra-392	41	32	age	age	NOUN
gra-392	41	33	of	of	ADP
gra-392	41	34	the	the	DET
gra-392	41	35	studied	study	VERB
gra-392	41	36	ckd	ckd	PROPN
gra-392	41	37	patients	patient	NOUN
gra-392	41	38	was	be	AUX
gra-392	41	39	45.46	45.46	NUM
gra-392	41	40	±	±	NUM
gra-392	41	41	15.60	15.60	NUM
gra-392	41	42	years	year	NOUN
gra-392	41	43	(	(	PUNCT
gra-392	41	44	range	range	NOUN
gra-392	41	45	1876	1876	NUM
gra-392	41	46	)	)	PUNCT
gra-392	41	47	.	.	PUNCT
gra-392	42	1	conclusion	conclusion	NOUN
gra-392	42	2	:	:	PUNCT
gra-392	42	3	magnesium	magnesium	NOUN
gra-392	42	4	may	may	AUX
gra-392	42	5	affect	affect	VERB
gra-392	42	6	the	the	DET
gra-392	42	7	metabolism	metabolism	NOUN
gra-392	42	8	of	of	ADP
gra-392	42	9	tg	tg	PROPN
gra-392	42	10	and	and	CCONJ
gra-392	42	11	hdl	hdl	PROPN
gra-392	42	12	in	in	ADP
gra-392	42	13	liver	liver	NOUN
gra-392	42	14	and	and	CCONJ
gra-392	42	15	kidneys	kidney	NOUN
gra-392	42	16	.	.	PUNCT
gra-392	43	1	the	the	DET
gra-392	43	2	association	association	NOUN
gra-392	43	3	of	of	ADP
gra-392	43	4	dyslipidemia	dyslipidemia	NOUN
gra-392	43	5	with	with	ADP
gra-392	43	6	serum	serum	NOUN
gra-392	43	7	mg	mg	PROPN
gra-392	43	8	levels	level	NOUN
gra-392	43	9	is	be	AUX
gra-392	43	10	not	not	PART
gra-392	43	11	clearly	clearly	ADV
gra-392	43	12	understood	understand	VERB
gra-392	43	13	,	,	PUNCT
gra-392	43	14	and	and	CCONJ
gra-392	43	15	further	further	ADJ
gra-392	43	16	large	large	ADJ
gra-392	43	17	clinical	clinical	ADJ
gra-392	43	18	studies	study	NOUN
gra-392	43	19	are	be	AUX
gra-392	43	20	needed	need	VERB
gra-392	43	21	to	to	PART
gra-392	43	22	understand	understand	VERB
gra-392	43	23	this	this	DET
gra-392	43	24	association	association	NOUN
gra-392	43	25	better	well	ADV
gra-392	43	26	.	.	PUNCT
gra-392	44	1	abstract	abstract	ADJ
gra-392	44	2	keywords	keyword	NOUN
gra-392	44	3	:	:	PUNCT
gra-392	44	4	esrd	esrd	PROPN
gra-392	44	5	,	,	PUNCT
gra-392	44	6	hemodialysis	hemodialysis	NOUN
gra-392	44	7	,	,	PUNCT
gra-392	44	8	mg	mg	PROPN
gra-392	44	9	,	,	PUNCT
gra-392	44	10	hdl	hdl	PROPN
gra-392	44	11	volume-8	volume-8	PROPN
gra-392	44	12	,	,	PUNCT
gra-392	44	13	issue-10	issue-10	NOUN
gra-392	44	14	,	,	PUNCT
gra-392	44	15	october-2019	october-2019	ADJ
gra-392	44	16	•	•	NUM
gra-392	44	17	print	print	NOUN
gra-392	44	18	issn	issn	PROPN
gra-392	44	19	no	no	NOUN
gra-392	44	20	.	.	PROPN
gra-392	44	21	2277	2277	NUM
gra-392	44	22	8160	8160	NUM
gra-392	44	23	•	•	NOUN
gra-392	44	24	doi	doi	NOUN
gra-392	44	25	:	:	PUNCT
gra-392	44	26	10.36106	10.36106	NUM
gra-392	44	27	/	/	SYM
gra-392	44	28	gjra	gjra	PROPN
gra-392	44	29	dr	dr	PROPN
gra-392	44	30	.	.	PROPN
gra-392	44	31	n.	n.	PROPN
gra-392	44	32	n.	n.	PROPN
gra-392	44	33	anand	anand	PROPN
gra-392	44	34	professor	professor	PROPN
gra-392	44	35	department	department	PROPN
gra-392	44	36	of	of	ADP
gra-392	44	37	general	general	ADJ
gra-392	44	38	medicine	medicine	NOUN
gra-392	44	39	,	,	PUNCT
gra-392	44	40	sree	sree	PROPN
gra-392	44	41	balaji	balaji	PROPN
gra-392	44	42	medical	medical	PROPN
gra-392	44	43	college	college	PROPN
gra-392	44	44	,	,	PUNCT
gra-392	44	45	chennai	chennai	PROPN
gra-392	44	46	,	,	PUNCT
gra-392	44	47	tamil	tamil	PROPN
gra-392	44	48	nadu	nadu	NOUN
gra-392	44	49	112	112	NUM
gra-392	44	50	x	x	SYM
gra-392	44	51	gjra	gjra	ADJ
gra-392	44	52	global	global	ADJ
gra-392	44	53	journal	journal	PROPN
gra-392	44	54	for	for	ADP
gra-392	44	55	research	research	NOUN
gra-392	44	56	analysis	analysis	NOUN
gra-392	44	57	statistical	statistical	ADJ
gra-392	44	58	methods	method	NOUN
gra-392	44	59	:	:	PUNCT
gra-392	44	60	for	for	ADP
gra-392	44	61	different	different	ADJ
gra-392	44	62	parameters	parameter	NOUN
gra-392	44	63	,	,	PUNCT
gra-392	44	64	mean	mean	ADJ
gra-392	44	65	and	and	CCONJ
gra-392	44	66	standard	standard	ADJ
gra-392	44	67	deviation	deviation	NOUN
gra-392	44	68	were	be	AUX
gra-392	44	69	calculated	calculate	VERB
gra-392	44	70	..	..	PUNCT
gra-392	45	1	the	the	DET
gra-392	45	2	values	value	NOUN
gra-392	45	3	of	of	ADP
gra-392	45	4	p	p	PRON
gra-392	45	5	which	which	PRON
gra-392	45	6	are	be	AUX
gra-392	45	7	<	<	X
gra-392	45	8	0.05	0.05	NUM
gra-392	45	9	were	be	AUX
gra-392	45	10	treated	treat	VERB
gra-392	45	11	as	as	ADP
gra-392	45	12	signicant	signicant	ADJ
gra-392	45	13	.	.	PUNCT
gra-392	46	1	the	the	DET
gra-392	46	2	qualitative	qualitative	ADJ
gra-392	46	3	variables	variable	NOUN
gra-392	46	4	(	(	PUNCT
gra-392	46	5	like	like	ADP
gra-392	46	6	sex	sex	NOUN
gra-392	46	7	,	,	PUNCT
gra-392	46	8	diabetes	diabetes	NOUN
gra-392	46	9	)	)	PUNCT
gra-392	46	10	were	be	AUX
gra-392	46	11	compared	compare	VERB
gra-392	46	12	using	use	VERB
gra-392	46	13	x2	x2	PROPN
gra-392	46	14	test	test	NOUN
gra-392	46	15	.	.	PUNCT
gra-392	47	1	the	the	DET
gra-392	47	2	statistical	statistical	ADJ
gra-392	47	3	software	software	NOUN
gra-392	47	4	spss	spss	PROPN
gra-392	47	5	ver	ver	PROPN
gra-392	47	6	.	.	PROPN
gra-392	47	7	20	20	NUM
gra-392	47	8	was	be	AUX
gra-392	47	9	used	use	VERB
gra-392	47	10	for	for	ADP
gra-392	47	11	statistical	statistical	ADJ
gra-392	47	12	analysis	analysis	NOUN
gra-392	47	13	.	.	PUNCT
gra-392	48	1	univariate	univariate	ADJ
gra-392	48	2	correlation	correlation	NOUN
gra-392	48	3	analysis	analysis	NOUN
gra-392	48	4	was	be	AUX
gra-392	48	5	used	use	VERB
gra-392	48	6	to	to	ADP
gra-392	48	7	conrm	conrm	PROPN
gra-392	48	8	the	the	DET
gra-392	48	9	signicance	signicance	NOUN
gra-392	48	10	of	of	ADP
gra-392	48	11	variables	variable	NOUN
gra-392	48	12	with	with	ADP
gra-392	48	13	serum	serum	NOUN
gra-392	48	14	magnesium	magnesium	NOUN
gra-392	48	15	levels	level	NOUN
gra-392	48	16	.	.	PUNCT
gra-392	49	1	results	result	NOUN
gra-392	49	2	:	:	PUNCT
gra-392	49	3	the	the	DET
gra-392	49	4	study	study	NOUN
gra-392	49	5	included	include	VERB
gra-392	49	6	50	50	NUM
gra-392	49	7	cases	case	NOUN
gra-392	49	8	of	of	ADP
gra-392	49	9	ckd	ckd	NOUN
gra-392	49	10	patients	patient	NOUN
gra-392	49	11	on	on	ADP
gra-392	49	12	dialysis	dialysis	NOUN
gra-392	49	13	;	;	PUNCT
gra-392	49	14	29	29	NUM
gra-392	49	15	male	male	NOUN
gra-392	49	16	and	and	CCONJ
gra-392	49	17	21	21	NUM
gra-392	49	18	females	female	NOUN
gra-392	49	19	.	.	PUNCT
gra-392	50	1	the	the	DET
gra-392	50	2	mean	mean	ADJ
gra-392	50	3	age	age	NOUN
gra-392	50	4	of	of	ADP
gra-392	50	5	the	the	DET
gra-392	50	6	studied	study	VERB
gra-392	50	7	ckd	ckd	PROPN
gra-392	50	8	patients	patient	NOUN
gra-392	50	9	was	be	AUX
gra-392	50	10	45.46	45.46	NUM
gra-392	50	11	±	±	NUM
gra-392	50	12	15.60	15.60	NUM
gra-392	50	13	years	year	NOUN
gra-392	50	14	(	(	PUNCT
gra-392	50	15	range	range	NOUN
gra-392	50	16	18	18	NUM
gra-392	50	17	-	-	SYM
gra-392	50	18	76	76	NUM
gra-392	50	19	)	)	PUNCT
gra-392	50	20	.	.	PUNCT
gra-392	51	1	maximum	maximum	ADJ
gra-392	51	2	patient	patient	NOUN
gra-392	51	3	in	in	ADP
gra-392	51	4	the	the	DET
gra-392	51	5	study	study	NOUN
gra-392	51	6	were	be	AUX
gra-392	51	7	in	in	ADP
gra-392	51	8	age	age	NOUN
gra-392	51	9	group	group	NOUN
gra-392	51	10	of	of	ADP
gra-392	51	11	50	50	NUM
gra-392	51	12	to	to	PART
gra-392	51	13	60	60	NUM
gra-392	51	14	years	year	NOUN
gra-392	51	15	.	.	PUNCT
gra-392	52	1	the	the	DET
gra-392	52	2	mean	mean	ADJ
gra-392	52	3	haemoglobin	haemoglobin	NOUN
gra-392	52	4	was	be	AUX
gra-392	52	5	8.86	8.86	NUM
gra-392	52	6	±	±	NUM
gra-392	52	7	1.71gm	1.71gm	NUM
gra-392	52	8	/	/	SYM
gra-392	52	9	dl	dl	PROPN
gra-392	52	10	,	,	PUNCT
gra-392	52	11	mean	mean	VERB
gra-392	52	12	blood	blood	NOUN
gra-392	52	13	urea	urea	NOUN
gra-392	52	14	was	be	AUX
gra-392	52	15	149.9±	149.9±	NUM
gra-392	52	16	60.81	60.81	NUM
gra-392	52	17	and	and	CCONJ
gra-392	52	18	mean	mean	ADJ
gra-392	52	19	creatinine	creatinine	NOUN
gra-392	52	20	was	be	AUX
gra-392	52	21	6.88	6.88	NUM
gra-392	52	22	±	±	NUM
gra-392	52	23	3.24	3.24	NUM
gra-392	52	24	mg	mg	PROPN
gra-392	52	25	/	/	SYM
gra-392	52	26	dl	dl	PROPN
gra-392	52	27	.	.	PROPN
gra-392	52	28	diabetes	diabetes	PROPN
gra-392	52	29	mellitus	mellitus	PROPN
gra-392	52	30	was	be	AUX
gra-392	52	31	the	the	DET
gra-392	52	32	etiology	etiology	NOUN
gra-392	52	33	of	of	ADP
gra-392	52	34	ckd	ckd	PROPN
gra-392	52	35	in	in	ADP
gra-392	52	36	28	28	NUM
gra-392	52	37	%	%	NOUN
gra-392	52	38	patients	patient	NOUN
gra-392	52	39	.	.	PUNCT
gra-392	53	1	the	the	DET
gra-392	53	2	serum	serum	NOUN
gra-392	53	3	magnesium	magnesium	NOUN
gra-392	53	4	was	be	AUX
gra-392	53	5	signicantly	signicantly	ADV
gra-392	53	6	correlated	correlate	VERB
gra-392	53	7	with	with	ADP
gra-392	53	8	diabetes	diabetes	NOUN
gra-392	53	9	in	in	ADP
gra-392	53	10	the	the	DET
gra-392	53	11	study	study	NOUN
gra-392	53	12	.	.	PUNCT
gra-392	54	1	(	(	PUNCT
gra-392	54	2	p	p	X
gra-392	54	3	<	<	X
gra-392	54	4	0.001	0.001	NUM
gra-392	54	5	)	)	PUNCT
gra-392	54	6	the	the	DET
gra-392	54	7	mean	mean	ADJ
gra-392	54	8	bmi	bmi	NOUN
gra-392	54	9	in	in	ADP
gra-392	54	10	ckd	ckd	PROPN
gra-392	54	11	patients	patient	NOUN
gra-392	54	12	was	be	AUX
gra-392	54	13	18.37	18.37	NUM
gra-392	54	14	±	±	NUM
gra-392	54	15	1.82	1.82	NUM
gra-392	54	16	kg	kg	NOUN
gra-392	54	17	/	/	SYM
gra-392	54	18	m2	m2	PROPN
gra-392	54	19	in	in	ADP
gra-392	54	20	the	the	DET
gra-392	54	21	present	present	ADJ
gra-392	54	22	study	study	NOUN
gra-392	54	23	most	most	ADJ
gra-392	54	24	of	of	ADP
gra-392	54	25	the	the	DET
gra-392	54	26	ckd	ckd	PROPN
gra-392	54	27	patients	patient	NOUN
gra-392	54	28	was	be	AUX
gra-392	54	29	in	in	ADP
gra-392	54	30	stage	stage	NOUN
gra-392	54	31	5	5	NUM
gra-392	54	32	.	.	PUNCT
gra-392	54	33	i.e.	i.e.	X
gra-392	54	34	43	43	NUM
gra-392	54	35	cases	case	NOUN
gra-392	54	36	.	.	PUNCT
gra-392	55	1	total	total	ADJ
gra-392	55	2	serum	serum	NOUN
gra-392	55	3	cholesterol	cholesterol	NOUN
gra-392	55	4	levels	level	NOUN
gra-392	55	5	(	(	PUNCT
gra-392	55	6	>	>	SYM
gra-392	55	7	200	200	NUM
gra-392	55	8	mg	mg	PROPN
gra-392	55	9	/	/	SYM
gra-392	55	10	dl	dl	PROPN
gra-392	55	11	)	)	PUNCT
gra-392	55	12	was	be	AUX
gra-392	55	13	found	find	VERB
gra-392	55	14	higher	high	ADJ
gra-392	55	15	than	than	ADP
gra-392	55	16	normal	normal	ADJ
gra-392	55	17	in	in	ADP
gra-392	55	18	15	15	NUM
gra-392	55	19	cases	case	NOUN
gra-392	55	20	and	and	CCONJ
gra-392	55	21	the	the	DET
gra-392	55	22	mean	mean	NOUN
gra-392	55	23	was	be	AUX
gra-392	55	24	174.1	174.1	NUM
gra-392	55	25	±	±	NUM
gra-392	55	26	44.62	44.62	NUM
gra-392	55	27	.	.	PUNCT
gra-392	56	1	the	the	DET
gra-392	56	2	mean	mean	ADJ
gra-392	56	3	serum	serum	NOUN
gra-392	56	4	triglyceride	triglyceride	PROPN
gra-392	56	5	levels	level	NOUN
gra-392	56	6	was	be	AUX
gra-392	56	7	144.54	144.54	NUM
gra-392	56	8	±	±	NUM
gra-392	56	9	58.09	58.09	NUM
gra-392	56	10	mg/	mg/	NOUN
gra-392	56	11	dl	dl	PROPN
gra-392	56	12	in	in	ADP
gra-392	56	13	ckd	ckd	PROPN
gra-392	56	14	patients	patient	NOUN
gra-392	56	15	and	and	CCONJ
gra-392	56	16	it	it	PRON
gra-392	56	17	correlated	correlate	VERB
gra-392	56	18	signicantly	signicantly	ADV
gra-392	56	19	with	with	ADP
gra-392	56	20	serum	serum	NOUN
gra-392	56	21	magnesium	magnesium	NOUN
gra-392	56	22	.	.	PUNCT
gra-392	57	1	the	the	DET
gra-392	57	2	mean	mean	ADJ
gra-392	57	3	hdl	hdl	PROPN
gra-392	57	4	-	-	PUNCT
gra-392	57	5	c	c	PROPN
gra-392	57	6	levels	level	NOUN
gra-392	57	7	was	be	AUX
gra-392	57	8	39.26	39.26	NUM
gra-392	57	9	±	±	NUM
gra-392	57	10	6.40	6.40	NUM
gra-392	57	11	mg	mg	PROPN
gra-392	57	12	/	/	SYM
gra-392	57	13	dl	dl	PROPN
gra-392	57	14	were	be	AUX
gra-392	57	15	lower	low	ADJ
gra-392	57	16	in	in	SCONJ
gra-392	57	17	ckd	ckd	PROPN
gra-392	57	18	patients	patient	NOUN
gra-392	57	19	found	find	VERB
gra-392	57	20	.	.	PUNCT
gra-392	58	1	in	in	ADP
gra-392	58	2	30	30	NUM
gra-392	58	3	patients	patient	NOUN
gra-392	58	4	among	among	ADP
gra-392	58	5	50	50	NUM
gra-392	58	6	cases	case	NOUN
gra-392	58	7	.	.	PUNCT
gra-392	59	1	serum	serum	NOUN
gra-392	59	2	magnesium	magnesium	NOUN
gra-392	59	3	in	in	ADP
gra-392	59	4	ckd	ckd	PROPN
gra-392	59	5	patients	patient	NOUN
gra-392	59	6	signicantly	signicantly	ADV
gra-392	59	7	correlated	correlate	VERB
gra-392	59	8	with	with	ADP
gra-392	59	9	age	age	NOUN
gra-392	59	10	(	(	PUNCT
gra-392	59	11	p	p	X
gra-392	59	12	<	<	X
gra-392	59	13	0.001	0.001	NUM
gra-392	59	14	)	)	PUNCT
gra-392	59	15	,	,	PUNCT
gra-392	59	16	systolic	systolic	ADJ
gra-392	59	17	blood	blood	NOUN
gra-392	59	18	pressure	pressure	NOUN
gra-392	59	19	(	(	PUNCT
gra-392	59	20	p<0.001),serum	p<0.001),serum	ADJ
gra-392	59	21	triglyceride	triglyceride	ADJ
gra-392	59	22	levels	level	NOUN
gra-392	59	23	(	(	PUNCT
gra-392	59	24	p=0.02	p=0.02	NOUN
gra-392	59	25	)	)	PUNCT
gra-392	59	26	,	,	PUNCT
gra-392	59	27	fbs	fbs	PROPN
gra-392	59	28	(	(	PUNCT
gra-392	59	29	p=	p=	NOUN
gra-392	59	30	0.04	0.04	NUM
gra-392	59	31	)	)	PUNCT
gra-392	59	32	.	.	PUNCT
gra-392	60	1	table-1genderwise	table-1genderwise	VERB
gra-392	60	2	distribution	distribution	NOUN
gra-392	60	3	of	of	ADP
gra-392	60	4	patients[total-50	patients[total-50	ADJ
gra-392	60	5	]	]	PUNCT
gra-392	60	6	table-2agewise	table-2agewise	ADJ
gra-392	60	7	distribution	distribution	NOUN
gra-392	60	8	of	of	ADP
gra-392	60	9	patients[total-50	patients[total-50	ADJ
gra-392	60	10	]	]	PUNCT
gra-392	60	11	table-3	table-3	NUM
gra-392	60	12	value	value	NOUN
gra-392	60	13	of	of	ADP
gra-392	60	14	s.	s.	PROPN
gra-392	60	15	magnesium	magnesium	PROPN
gra-392	60	16	in	in	ADP
gra-392	60	17	patients[total-50	patients[total-50	NOUN
gra-392	60	18	]	]	PUNCT
gra-392	60	19	table-4	table-4	NUM
gra-392	60	20	basic	basic	ADJ
gra-392	60	21	clinical	clinical	ADJ
gra-392	60	22	and	and	CCONJ
gra-392	60	23	laboratory	laboratory	NOUN
gra-392	60	24	characteristic	characteristic	NOUN
gra-392	60	25	of	of	ADP
gra-392	60	26	study	study	NOUN
gra-392	60	27	table	table	NOUN
gra-392	60	28	5	5	NUM
gra-392	60	29	correlation	correlation	NOUN
gra-392	60	30	with	with	ADP
gra-392	60	31	respect	respect	NOUN
gra-392	60	32	to	to	ADP
gra-392	60	33	serum	serum	NOUN
gra-392	60	34	magnesium	magnesium	NOUN
gra-392	60	35	:	:	PUNCT
gra-392	60	36	discussion	discussion	NOUN
gra-392	60	37	:	:	PUNCT
gra-392	60	38	in	in	ADP
gra-392	60	39	our	our	PRON
gra-392	60	40	study	study	NOUN
gra-392	60	41	,	,	PUNCT
gra-392	60	42	the	the	DET
gra-392	60	43	lipid	lipid	NOUN
gra-392	60	44	prole	prole	PROPN
gra-392	60	45	was	be	AUX
gra-392	60	46	derranged	derrange	VERB
gra-392	60	47	in	in	ADP
gra-392	60	48	relation	relation	NOUN
gra-392	60	49	to	to	PART
gra-392	60	50	serum	serum	NOUN
gra-392	60	51	magnesium	magnesium	NOUN
gra-392	60	52	.	.	PUNCT
gra-392	61	1	magnesium	magnesium	NOUN
gra-392	61	2	showed	show	VERB
gra-392	61	3	positive	positive	ADJ
gra-392	61	4	correlation	correlation	NOUN
gra-392	61	5	with	with	ADP
gra-392	61	6	hdl	hdl	PROPN
gra-392	61	7	.	.	PUNCT
gra-392	62	1	ie	ie	X
gra-392	62	2	(	(	PUNCT
gra-392	62	3	p=	p=	NOUN
gra-392	62	4	0.14	0.14	NUM
gra-392	62	5	)	)	PUNCT
gra-392	62	6	but	but	CCONJ
gra-392	62	7	was	be	AUX
gra-392	62	8	not	not	PART
gra-392	62	9	signicant	signicant	ADJ
gra-392	62	10	.	.	PUNCT
gra-392	63	1	the	the	DET
gra-392	63	2	magnesium	magnesium	NOUN
gra-392	63	3	was	be	AUX
gra-392	63	4	signicantly	signicantly	ADV
gra-392	63	5	negatively	negatively	ADV
gra-392	63	6	correlated	correlate	VERB
gra-392	63	7	with	with	ADP
gra-392	63	8	serum	serum	NOUN
gra-392	63	9	triglycerides	triglyceride	NOUN
gra-392	63	10	,	,	PUNCT
gra-392	63	11	with	with	ADP
gra-392	63	12	p	p	NOUN
gra-392	63	13	value	value	NOUN
gra-392	63	14	(	(	PUNCT
gra-392	63	15	p	p	X
gra-392	63	16	<	<	X
gra-392	63	17	0.001	0.001	NUM
gra-392	63	18	)	)	PUNCT
gra-392	63	19	.	.	PUNCT
gra-392	64	1	magnesium	magnesium	NOUN
gra-392	64	2	was	be	AUX
gra-392	64	3	negatively	negatively	ADV
gra-392	64	4	correlated	correlate	VERB
gra-392	64	5	with	with	ADP
gra-392	64	6	total	total	ADJ
gra-392	64	7	cholesterol	cholesterol	NOUN
gra-392	64	8	levels	level	NOUN
gra-392	64	9	p	p	NOUN
gra-392	64	10	value	value	NOUN
gra-392	64	11	(	(	PUNCT
gra-392	64	12	p	p	X
gra-392	64	13	=	=	NOUN
gra-392	64	14	0.096	0.096	NUM
gra-392	64	15	)	)	PUNCT
gra-392	64	16	which	which	PRON
gra-392	64	17	is	be	AUX
gra-392	64	18	not	not	PART
gra-392	64	19	signicant	signicant	ADJ
gra-392	64	20	.	.	PUNCT
gra-392	65	1	thus	thus	ADV
gra-392	65	2	the	the	DET
gra-392	65	3	lower	low	ADJ
gra-392	65	4	serum	serum	NOUN
gra-392	65	5	magnesium	magnesium	NOUN
gra-392	65	6	level	level	NOUN
gra-392	65	7	may	may	AUX
gra-392	65	8	be	be	AUX
gra-392	65	9	associated	associate	VERB
gra-392	65	10	with	with	ADP
gra-392	65	11	dyslipidemia	dyslipidemia	NOUN
gra-392	65	12	in	in	ADP
gra-392	65	13	patients	patient	NOUN
gra-392	65	14	on	on	ADP
gra-392	65	15	maintance	maintance	ADJ
gra-392	65	16	hemodialysis	hemodialysis	NOUN
gra-392	65	17	the	the	DET
gra-392	65	18	pattern	pattern	NOUN
gra-392	65	19	of	of	ADP
gra-392	65	20	dyslipidemia	dyslipidemia	NOUN
gra-392	65	21	in	in	ADP
gra-392	65	22	our	our	PRON
gra-392	65	23	study	study	NOUN
gra-392	65	24	showed	show	VERB
gra-392	65	25	hypertriglyceridemia	hypertriglyceridemia	NOUN
gra-392	65	26	,	,	PUNCT
gra-392	65	27	increases	increase	VERB
gra-392	65	28	cholesterol	cholesterol	NOUN
gra-392	65	29	and	and	CCONJ
gra-392	65	30	decreased	decrease	VERB
gra-392	65	31	hdl	hdl	PROPN
gra-392	65	32	.	.	PUNCT
gra-392	66	1	these	these	DET
gra-392	66	2	lipid	lipid	ADJ
gra-392	66	3	abnormalities	abnormality	NOUN
gra-392	66	4	are	be	AUX
gra-392	66	5	well	well	ADV
gra-392	66	6	recognised	recognise	VERB
gra-392	66	7	risk	risk	NOUN
gra-392	66	8	factors	factor	NOUN
gra-392	66	9	for	for	ADP
gra-392	66	10	atherosclerotic	atherosclerotic	ADJ
gra-392	66	11	vascular	vascular	ADJ
gra-392	66	12	disease	disease	NOUN
gra-392	66	13	in	in	ADP
gra-392	66	14	hd	hd	NOUN
gra-392	66	15	patients	patient	NOUN
gra-392	66	16	and	and	CCONJ
gra-392	66	17	thus	thus	ADV
gra-392	66	18	there	there	PRON
gra-392	66	19	is	be	VERB
gra-392	66	20	strong	strong	ADJ
gra-392	66	21	need	need	NOUN
gra-392	66	22	to	to	PART
gra-392	66	23	focus	focus	VERB
gra-392	66	24	on	on	ADP
gra-392	66	25	underlying	underlie	VERB
gra-392	66	26	causes	cause	NOUN
gra-392	66	27	and	and	CCONJ
gra-392	66	28	treatment	treatment	NOUN
gra-392	66	29	of	of	ADP
gra-392	66	30	hyperlipidemia	hyperlipidemia	NOUN
gra-392	66	31	.	.	PUNCT
gra-392	67	1	in	in	ADP
gra-392	67	2	j.	j.	PROPN
gra-392	67	3	elementol	elementol	PROPN
gra-392	67	4	,	,	PUNCT
gra-392	67	5	no	no	DET
gra-392	67	6	statistically	statistically	ADV
gra-392	67	7	signicant	signicant	ADJ
gra-392	67	8	effect	effect	NOUN
gra-392	67	9	of	of	ADP
gra-392	67	10	magnesium	magnesium	NOUN
gra-392	67	11	concentration	concentration	NOUN
gra-392	67	12	on	on	ADP
gra-392	67	13	the	the	DET
gra-392	67	14	content	content	NOUN
gra-392	67	15	of	of	ADP
gra-392	67	16	lipids	lipid	NOUN
gra-392	67	17	analysed	analyse	VERB
gra-392	67	18	in	in	ADP
gra-392	67	19	blood	blood	NOUN
gra-392	67	20	serum	serum	NOUN
gra-392	67	21	was	be	AUX
gra-392	67	22	found	find	VERB
gra-392	67	23	..	..	PUNCT
gra-392	67	24	magnesium	magnesium	NOUN
gra-392	67	25	content	content	NOUN
gra-392	67	26	in	in	ADP
gra-392	67	27	blood	blood	NOUN
gra-392	67	28	serum	serum	NOUN
gra-392	67	29	was	be	AUX
gra-392	67	30	also	also	ADV
gra-392	67	31	positively	positively	ADV
gra-392	67	32	correlated	correlate	VERB
gra-392	67	33	with	with	ADP
gra-392	67	34	hdl	hdl	PROPN
gra-392	67	35	cholesterol	cholesterol	NOUN
gra-392	67	36	in	in	ADP
gra-392	67	37	men	man	NOUN
gra-392	67	38	of	of	ADP
gra-392	67	39	both	both	DET
gra-392	67	40	groups	group	NOUN
gra-392	67	41	.	.	PUNCT
gra-392	68	1	a	a	DET
gra-392	68	2	positive	positive	ADJ
gra-392	68	3	effect	effect	NOUN
gra-392	68	4	on	on	ADP
gra-392	68	5	ldl	ldl	NOUN
gra-392	68	6	-	-	PUNCT
gra-392	68	7	cholesterol	cholesterol	NOUN
gra-392	68	8	was	be	AUX
gra-392	68	9	observed	observe	VERB
gra-392	68	10	in	in	ADP
gra-392	68	11	the	the	DET
gra-392	68	12	group	group	NOUN
gra-392	68	13	of	of	ADP
gra-392	68	14	older	old	ADJ
gra-392	68	15	women	woman	NOUN
gra-392	68	16	and	and	CCONJ
gra-392	68	17	that	that	PRON
gra-392	68	18	of	of	ADP
gra-392	68	19	younger	young	ADJ
gra-392	68	20	men	man	NOUN
gra-392	68	21	.	.	PUNCT
gra-392	69	1	however	however	ADV
gra-392	69	2	,	,	PUNCT
gra-392	69	3	also	also	ADV
gra-392	69	4	small	small	ADJ
gra-392	69	5	negative	negative	ADJ
gra-392	69	6	correlation	correlation	NOUN
gra-392	69	7	between	between	ADP
gra-392	69	8	mg	mg	PROPN
gra-392	69	9	and	and	CCONJ
gra-392	69	10	ldlcholesterol	ldlcholesterol	VERB
gra-392	69	11	contents	content	NOUN
gra-392	69	12	was	be	AUX
gra-392	69	13	obtained	obtain	VERB
gra-392	69	14	in	in	ADP
gra-392	69	15	older	old	ADJ
gra-392	69	16	men	man	NOUN
gra-392	69	17	.	.	PUNCT
gra-392	70	1	similarly	similarly	ADV
gra-392	70	2	we	we	PRON
gra-392	70	3	found	find	VERB
gra-392	70	4	positive	positive	ADJ
gra-392	70	5	correlation	correlation	NOUN
gra-392	70	6	of	of	ADP
gra-392	70	7	serum	serum	NOUN
gra-392	70	8	magnesium	magnesium	NOUN
gra-392	70	9	with	with	ADP
gra-392	70	10	hdl	hdl	PROPN
gra-392	70	11	and	and	CCONJ
gra-392	70	12	negative	negative	ADJ
gra-392	70	13	correlation	correlation	NOUN
gra-392	70	14	of	of	ADP
gra-392	70	15	magnesium	magnesium	NOUN
gra-392	70	16	with	with	ADP
gra-392	70	17	cholesterol	cholesterol	NOUN
gra-392	70	18	and	and	CCONJ
gra-392	70	19	triglycerides	triglyceride	NOUN
gra-392	70	20	.	.	PUNCT
gra-392	71	1	in	in	ADP
gra-392	71	2	nasri	nasri	PROPN
gra-392	71	3	,	,	PUNCT
gra-392	71	4	baradaran	baradaran	VERB
gra-392	71	5	et	et	PROPN
gra-392	71	6	al	al	PROPN
gra-392	71	7	2004	2004	PROPN
gra-392	71	8	.	.	PUNCT
gra-392	72	1	meaningful	meaningful	ADJ
gra-392	72	2	positive	positive	ADJ
gra-392	72	3	correlation	correlation	NOUN
gra-392	72	4	(	(	PUNCT
gra-392	72	5	hut	hut	NOUN
gra-392	72	6	statistically	statistically	ADV
gra-392	72	7	non	non	ADJ
gra-392	72	8	-	-	ADJ
gra-392	72	9	signicant	signicant	ADJ
gra-392	72	10	)	)	PUNCT
gra-392	72	11	was	be	AUX
gra-392	72	12	obtained	obtain	VERB
gra-392	72	13	between	between	ADP
gra-392	72	14	mg	mg	PROPN
gra-392	72	15	and	and	CCONJ
gra-392	72	16	total	total	ADJ
gra-392	72	17	cholesterol	cholesterol	NOUN
gra-392	72	18	.	.	PUNCT
gra-392	73	1	in	in	ADP
gra-392	73	2	feng	feng	PROPN
gra-392	73	3	liu	liu	PROPN
gra-392	73	4	et	et	PROPN
gra-392	73	5	al	al	PROPN
gra-392	73	6	,	,	PUNCT
gra-392	73	7	98	98	NUM
gra-392	73	8	chronic	chronic	ADJ
gra-392	73	9	hd	hd	NOUN
gra-392	73	10	patients	patient	NOUN
gra-392	73	11	were	be	AUX
gra-392	73	12	recruited	recruit	VERB
gra-392	73	13	,	,	PUNCT
gra-392	73	14	)	)	PUNCT
gra-392	73	15	,	,	PUNCT
gra-392	73	16	high	high	ADJ
gra-392	73	17	-	-	PUNCT
gra-392	73	18	density	density	NOUN
gra-392	73	19	lipoprotein	lipoprotein	ADJ
gra-392	73	20	cholesterol	cholesterol	NOUN
gra-392	73	21	(	(	PUNCT
gra-392	73	22	hdl	hdl	NOUN
gra-392	73	23	-	-	PUNCT
gra-392	73	24	c	c	NOUN
gra-392	73	25	)	)	PUNCT
gra-392	73	26	levels	level	NOUN
gra-392	73	27	,	,	PUNCT
gra-392	73	28	carotid	carotid	NOUN
gra-392	73	29	artery	artery	NOUN
gra-392	73	30	plaque	plaque	NOUN
gra-392	73	31	(	(	PUNCT
gra-392	73	32	cap	cap	NOUN
gra-392	73	33	)	)	PUNCT
gra-392	73	34	,	,	PUNCT
gra-392	73	35	and	and	CCONJ
gra-392	73	36	carotid	carotid	VERB
gra-392	73	37	intima	intima	ADJ
gra-392	73	38	-	-	PUNCT
gra-392	73	39	media	media	NOUN
gra-392	73	40	thickness	thickness	NOUN
gra-392	73	41	(	(	PUNCT
gra-392	73	42	cimt	cimt	NOUN
gra-392	73	43	)	)	PUNCT
gra-392	73	44	'	'	PUNCT
gra-392	73	45	(	(	PUNCT
gra-392	73	46	all	all	DET
gra-392	73	47	p<0.05	p<0.05	NOUN
gra-392	73	48	,	,	PUNCT
gra-392	73	49	respectively	respectively	ADV
gra-392	73	50	)	)	PUNCT
gra-392	73	51	were	be	AUX
gra-392	73	52	higher	high	ADJ
gra-392	73	53	in	in	ADP
gra-392	73	54	patients	patient	NOUN
gra-392	73	55	with	with	ADP
gra-392	73	56	low	low	ADJ
gra-392	73	57	serum	serum	NOUN
gra-392	73	58	magnesium	magnesium	NOUN
gra-392	73	59	there	there	PRON
gra-392	73	60	was	be	VERB
gra-392	73	61	no	no	DET
gra-392	73	62	signicant	signicant	ADJ
gra-392	73	63	correlation	correlation	NOUN
gra-392	73	64	between	between	ADP
gra-392	73	65	mg	mg	PROPN
gra-392	73	66	and	and	CCONJ
gra-392	73	67	low	low	ADJ
gra-392	73	68	-	-	PUNCT
gra-392	73	69	density	density	NOUN
gra-392	73	70	lipoprotein	lipoprotein	ADJ
gra-392	73	71	cholesterol	cholesterol	NOUN
gra-392	73	72	(	(	PUNCT
gra-392	73	73	ldl	ldl	NOUN
gra-392	73	74	-	-	PUNCT
gra-392	73	75	c	c	NOUN
gra-392	73	76	)	)	PUNCT
gra-392	73	77	,	,	PUNCT
gra-392	73	78	lipoprotein	lipoprotein	NOUN
gra-392	73	79	-	-	PUNCT
gra-392	73	80	a	a	DET
gra-392	73	81	(	(	PUNCT
gra-392	73	82	lp	lp	NOUN
gra-392	73	83	-	-	PUNCT
gra-392	73	84	a	a	NOUN
gra-392	73	85	)	)	PUNCT
gra-392	73	86	,	,	PUNCT
gra-392	73	87	cholesterol	cholesterol	NOUN
gra-392	73	88	(	(	PUNCT
gra-392	73	89	tc	tc	NOUN
gra-392	73	90	)	)	PUNCT
gra-392	73	91	,	,	PUNCT
gra-392	73	92	serum	serum	NOUN
gra-392	73	93	triglycerides	triglyceride	NOUN
gra-392	73	94	(	(	PUNCT
gra-392	73	95	tg	tg	NOUN
gra-392	73	96	)	)	PUNCT
gra-392	73	97	(	(	PUNCT
gra-392	73	98	p>0.05	p>0.05	NOUN
gra-392	73	99	,	,	PUNCT
gra-392	74	1	respectively)in	respectively)in	NOUN
gra-392	74	2	contrast	contrast	NOUN
gra-392	74	3	we	we	PRON
gra-392	74	4	found	find	VERB
gra-392	74	5	signicant	signicant	ADJ
gra-392	74	6	correlation	correlation	NOUN
gra-392	74	7	with	with	ADP
gra-392	74	8	triglycerides	triglyceride	NOUN
gra-392	74	9	and	and	CCONJ
gra-392	74	10	non	non	ADJ
gra-392	74	11	signicant	signicant	ADJ
gra-392	74	12	with	with	ADP
gra-392	74	13	cholesterol	cholesterol	NOUN
gra-392	74	14	and	and	CCONJ
gra-392	74	15	hdl.in	hdl.in	PROPN
gra-392	74	16	ansari	ansari	ADJ
gra-392	74	17	mr	mr	PROPN
gra-392	74	18	et	et	PROPN
gra-392	74	19	al	al	PROPN
gra-392	74	20	,	,	PUNCT
gra-392	74	21	studied	study	VERB
gra-392	74	22	50	50	NUM
gra-392	74	23	patients	patient	NOUN
gra-392	74	24	and	and	CCONJ
gra-392	74	25	concludes	conclude	VERB
gra-392	74	26	that	that	SCONJ
gra-392	74	27	there	there	PRON
gra-392	74	28	was	be	VERB
gra-392	74	29	a	a	DET
gra-392	74	30	signicant	signicant	ADJ
gra-392	74	31	positive	positive	ADJ
gra-392	74	32	correlation	correlation	NOUN
gra-392	74	33	between	between	ADP
gra-392	74	34	serum	serum	NOUN
gra-392	74	35	mg	mg	PROPN
gra-392	74	36	and	and	CCONJ
gra-392	74	37	serum	serum	VERB
gra-392	74	38	lipoprotein	lipoprotein	NOUN
gra-392	74	39	-	-	PUNCT
gra-392	74	40	a	a	NOUN
gra-392	74	41	(	(	PUNCT
gra-392	74	42	r	r	NOUN
gra-392	74	43	=	=	SYM
gra-392	74	44	(	(	PUNCT
gra-392	74	45	(	(	PUNCT
gra-392	74	46	p	p	NOUN
gra-392	74	47	-	-	PUNCT
gra-392	74	48	a	a	NOUN
gra-392	74	49	)	)	PUNCT
gra-392	74	50	0.40	0.40	NUM
gra-392	74	51	.	.	PUNCT
gra-392	75	1	p	p	X
gra-392	75	2	c	c	NOUN
gra-392	75	3	0.007	0.007	NUM
gra-392	75	4	)	)	PUNCT
gra-392	75	5	,	,	PUNCT
gra-392	75	6	serum	serum	PROPN
gra-392	75	7	hdl	hdl	PROPN
gra-392	75	8	(	(	PUNCT
gra-392	75	9	r	r	NOUN
gra-392	75	10	=	=	SYM
gra-392	75	11	0.31	0.31	NUM
gra-392	75	12	,	,	PUNCT
gra-392	75	13	p	p	X
gra-392	75	14	<	<	X
gra-392	75	15	0.01	0.01	NUM
gra-392	75	16	)	)	PUNCT
gra-392	75	17	and	and	CCONJ
gra-392	75	18	serum	serum	NOUN
gra-392	75	19	tg	tg	PROPN
gra-392	75	20	(	(	PUNCT
gra-392	75	21	r	r	NOUN
gra-392	75	22	=	=	SYM
gra-392	75	23	0.35	0.35	NUM
gra-392	75	24	,	,	PUNCT
gra-392	75	25	p	p	X
gra-392	75	26	<	<	X
gra-392	75	27	0.005	0.005	NUM
gra-392	75	28	)	)	PUNCT
gra-392	75	29	.	.	PUNCT
gra-392	76	1	there	there	PRON
gra-392	76	2	was	be	VERB
gra-392	76	3	no	no	DET
gra-392	76	4	signicant	signicant	ADJ
gra-392	76	5	correlation	correlation	NOUN
gra-392	76	6	between	between	ADP
gra-392	76	7	serum	serum	NOUN
gra-392	76	8	mg	mg	PROPN
gra-392	76	9	and	and	CCONJ
gra-392	76	10	serum	serum	VERB
gra-392	76	11	ldl	ldl	PROPN
gra-392	76	12	-	-	PUNCT
gra-392	76	13	c	c	PROPN
gra-392	76	14	and	and	CCONJ
gra-392	76	15	serum	serum	PROPN
gra-392	76	16	tc	tc	PROPN
gra-392	76	17	.	.	PUNCT
gra-392	77	1	the	the	DET
gra-392	77	2	serum	serum	NOUN
gra-392	77	3	tg	tg	PROPN
gra-392	77	4	and	and	CCONJ
gra-392	77	5	lp	lp	PROPN
gra-392	77	6	-	-	PUNCT
gra-392	77	7	a	a	DET
gra-392	77	8	levels	level	NOUN
gra-392	77	9	were	be	AUX
gra-392	77	10	signicantly	signicantly	ADV
gra-392	77	11	increased	increase	VERB
gra-392	77	12	while	while	SCONJ
gra-392	77	13	hdl	hdl	PROPN
gra-392	77	14	-	-	PUNCT
gra-392	77	15	c	c	PROPN
gra-392	77	16	was	be	AUX
gra-392	77	17	signicantly	signicantly	ADV
gra-392	77	18	lower	low	ADJ
gra-392	77	19	in	in	ADP
gra-392	77	20	mhd	mhd	NOUN
gra-392	77	21	patients	patient	NOUN
gra-392	77	22	.	.	PUNCT
gra-392	78	1	the	the	DET
gra-392	78	2	serum	serum	PROPN
gra-392	78	3	tc	tc	NOUN
gra-392	78	4	,	,	PUNCT
gra-392	78	5	ldl	ldl	NOUN
gra-392	78	6	-	-	PUNCT
gra-392	78	7	c	c	PROPN
gra-392	78	8	and	and	CCONJ
gra-392	78	9	very	very	ADV
gra-392	78	10	lowdensity	lowdensity	NOUN
gra-392	78	11	lipoprotein	lipoprotein	NOUN
gra-392	78	12	-	-	PUNCT
gra-392	78	13	c	c	NOUN
gra-392	78	14	were	be	AUX
gra-392	78	15	not	not	PART
gra-392	78	16	signicantly	signicantly	ADV
gra-392	78	17	elevated	elevate	VERB
gra-392	78	18	.	.	PUNCT
gra-392	79	1	in	in	ADP
gra-392	79	2	robles	robles	PROPN
gra-392	79	3	nit	nit	PROPN
gra-392	79	4	et	et	PROPN
gra-392	79	5	al	al	PROPN
gra-392	79	6	,	,	PUNCT
gra-392	79	7	twenty-ve	twenty-ve	NOUN
gra-392	79	8	hemodialysis	hemodialysis	NOUN
gra-392	79	9	patients	patient	NOUN
gra-392	79	10	volume-8	volume-8	NUM
gra-392	79	11	,	,	PUNCT
gra-392	79	12	issue-10	issue-10	NOUN
gra-392	79	13	,	,	PUNCT
gra-392	79	14	october-2019	october-2019	ADJ
gra-392	79	15	•	•	NUM
gra-392	79	16	print	print	NOUN
gra-392	79	17	issn	issn	PROPN
gra-392	79	18	no	no	NOUN
gra-392	79	19	.	.	PROPN
gra-392	79	20	2277	2277	NUM
gra-392	79	21	8160	8160	NUM
gra-392	79	22	•	•	NOUN
gra-392	79	23	doi	doi	NOUN
gra-392	79	24	:	:	PUNCT
gra-392	79	25	10.36106	10.36106	NUM
gra-392	79	26	/	/	SYM
gra-392	79	27	gjra	gjra	NOUN
gra-392	79	28	gender	gender	NOUN
gra-392	79	29	total	total	NOUN
gra-392	79	30	no	no	INTJ
gra-392	79	31	of	of	ADP
gra-392	79	32	pts	pt	NOUN
gra-392	79	33	%	%	NOUN
gra-392	79	34	male	male	ADJ
gra-392	79	35	29	29	NUM
gra-392	79	36	58	58	NUM
gra-392	79	37	%	%	NOUN
gra-392	79	38	female	female	ADJ
gra-392	79	39	21	21	NUM
gra-392	79	40	42	42	NUM
gra-392	79	41	%	%	NOUN
gra-392	79	42	age[yr	age[yr	NOUN
gra-392	79	43	]	]	X
gra-392	79	44	<	<	X
gra-392	79	45	20	20	NUM
gra-392	79	46	21	21	NUM
gra-392	79	47	-	-	SYM
gra-392	79	48	30	30	NUM
gra-392	79	49	31	31	NUM
gra-392	79	50	-	-	SYM
gra-392	79	51	40	40	NUM
gra-392	79	52	41	41	NUM
gra-392	79	53	-	-	SYM
gra-392	79	54	50	50	NUM
gra-392	79	55	51	51	NUM
gra-392	79	56	-	-	SYM
gra-392	79	57	60	60	NUM
gra-392	79	58	>	>	SYM
gra-392	79	59	60	60	NUM
gra-392	79	60	no	no	NOUN
gra-392	79	61	of	of	ADP
gra-392	79	62	pts	pt	NOUN
gra-392	79	63	2	2	NUM
gra-392	79	64	10	10	NUM
gra-392	79	65	10	10	NUM
gra-392	79	66	8	8	NUM
gra-392	79	67	12	12	NUM
gra-392	79	68	8	8	NUM
gra-392	79	69	total	total	NOUN
gra-392	79	70	hypomagne	hypomagne	NOUN
gra-392	79	71	saemia	saemia	PROPN
gra-392	80	1	normal	normal	ADJ
gra-392	80	2	magnesium	magnesium	NOUN
gra-392	80	3	hypomagne	hypomagne	NOUN
gra-392	80	4	saemia	saemia	PROPN
gra-392	80	5	50	50	NUM
gra-392	80	6	13	13	NUM
gra-392	80	7	13	13	NUM
gra-392	80	8	24	24	NUM
gra-392	80	9	parameters	parameter	NOUN
gra-392	80	10	mean	mean	VERB
gra-392	80	11	±	±	NUM
gra-392	80	12	sd	sd	ADP
gra-392	80	13	age	age	NOUN
gra-392	80	14	45.46	45.46	NUM
gra-392	80	15	±	±	NUM
gra-392	80	16	15.60	15.60	NUM
gra-392	80	17	sex(m	sex(m	PROPN
gra-392	80	18	/	/	SYM
gra-392	80	19	f	f	NOUN
gra-392	80	20	)	)	PUNCT
gra-392	80	21	29	29	NUM
gra-392	80	22	/	/	SYM
gra-392	80	23	21	21	NUM
gra-392	80	24	height	height	NOUN
gra-392	80	25	158.94	158.94	NUM
gra-392	80	26	=	=	SYM
gra-392	80	27	8.37	8.37	NUM
gra-392	80	28	weight	weight	NOUN
gra-392	80	29	46.46	46.46	NUM
gra-392	80	30	±	±	NUM
gra-392	80	31	5.07	5.07	NUM
gra-392	80	32	bmi	bmi	NOUN
gra-392	80	33	18.37±	18.37±	NUM
gra-392	80	34	1.82	1.82	NUM
gra-392	80	35	diabetes	diabetes	NOUN
gra-392	80	36	(	(	PUNCT
gra-392	80	37	y	y	PROPN
gra-392	80	38	/	/	SYM
gra-392	80	39	n	n	PROPN
gra-392	80	40	)	)	PUNCT
gra-392	80	41	14	14	NUM
gra-392	80	42	/	/	SYM
gra-392	80	43	36	36	NUM
gra-392	80	44	pulse	pulse	NOUN
gra-392	80	45	74.5±14.80	74.5±14.80	NOUN
gra-392	80	46	systolic	systolic	ADJ
gra-392	80	47	blood	blood	NOUN
gra-392	80	48	pressure	pressure	NOUN
gra-392	80	49	162.24	162.24	NUM
gra-392	80	50	±	±	NUM
gra-392	80	51	20.40	20.40	NUM
gra-392	80	52	diastolic	diastolic	NOUN
gra-392	80	53	blood	blood	NOUN
gra-392	80	54	pressure	pressure	NOUN
gra-392	80	55	98.08	98.08	NUM
gra-392	80	56	+	+	SYM
gra-392	80	57	12.45	12.45	NUM
gra-392	80	58	haemoglobin	haemoglobin	NOUN
gra-392	80	59	8.861	8.861	NUM
gra-392	80	60	1.71fasting	1.71fasting	NOUN
gra-392	80	61	blood	blood	NOUN
gra-392	80	62	sugar	sugar	NOUN
gra-392	80	63	126.8	126.8	NUM
gra-392	80	64	±	±	NUM
gra-392	80	65	74.24	74.24	NUM
gra-392	80	66	blood	blood	NOUN
gra-392	80	67	urea	urea	NOUN
gra-392	80	68	149.9	149.9	NUM
gra-392	80	69	±	±	NUM
gra-392	80	70	60.81	60.81	NUM
gra-392	80	71	serum	serum	NOUN
gra-392	80	72	creatinine	creatinine	NOUN
gra-392	80	73	6.88	6.88	NUM
gra-392	80	74	±	±	NUM
gra-392	80	75	3.24	3.24	NUM
gra-392	80	76	gfr	gfr	NOUN
gra-392	80	77	10.95	10.95	NUM
gra-392	80	78	±	±	NUM
gra-392	80	79	714	714	NUM
gra-392	80	80	number	number	NOUN
gra-392	80	81	of	of	ADP
gra-392	80	82	dialysis	dialysis	NOUN
gra-392	80	83	20.98	20.98	NUM
gra-392	80	84	±14.48	±14.48	X
gra-392	80	85	serum	serum	NOUN
gra-392	80	86	albumin	albumin	NOUN
gra-392	80	87	3.01	3.01	NUM
gra-392	80	88	±	±	NUM
gra-392	80	89	0.56	0.56	NUM
gra-392	80	90	hdl	hdl	X
gra-392	80	91	39.26	39.26	NUM
gra-392	80	92	±	±	NUM
gra-392	80	93	6.40	6.40	NUM
gra-392	80	94	triglycerides	triglyceride	NOUN
gra-392	80	95	144.54	144.54	NUM
gra-392	80	96	±58.09	±58.09	ADP
gra-392	80	97	total	total	ADJ
gra-392	80	98	cholesterol	cholesterol	NOUN
gra-392	80	99	174.1	174.1	NUM
gra-392	80	100	±	±	NUM
gra-392	80	101	44.62	44.62	NUM
gra-392	80	102	magnesium	magnesium	NOUN
gra-392	80	103	2.35	2.35	NUM
gra-392	80	104	±	±	NUM
gra-392	80	105	0.98	0.98	NUM
gra-392	80	106	parameters	parameter	NOUN
gra-392	80	107	p	p	NOUN
gra-392	80	108	r	r	NOUN
gra-392	80	109	age	age	NOUN
gra-392	80	110	0.001	0.001	NUM
gra-392	80	111	[	[	X
gra-392	80	112	s	s	X
gra-392	80	113	]	]	X
gra-392	80	114	-0.523	-0.523	NOUN
gra-392	80	115	height	height	NOUN
gra-392	80	116	0.551	0.551	NUM
gra-392	80	117	-0.086	-0.086	PUNCT
gra-392	80	118	weight	weight	NOUN
gra-392	80	119	0.363	0.363	NUM
gra-392	80	120	-0.131	-0.131	PUNCT
gra-392	80	121	bmi	bmi	PROPN
gra-392	80	122	0.692	0.692	NUM
gra-392	80	123	-0.057	-0.057	NOUN
gra-392	80	124	pulse	pulse	NOUN
gra-392	80	125	0:288	0:288	NOUN
gra-392	80	126	-0.153	-0.153	NOUN
gra-392	80	127	systolic	systolic	ADJ
gra-392	80	128	blood	blood	NOUN
gra-392	80	129	pressure	pressure	NOUN
gra-392	80	130	0.001	0.001	NUM
gra-392	81	1	[	[	X
gra-392	81	2	s	s	X
gra-392	81	3	]	]	X
gra-392	81	4	-0.459	-0.459	INTJ
gra-392	81	5	diastolic	diastolic	ADJ
gra-392	81	6	blood	blood	NOUN
gra-392	81	7	pressure	pressure	NOUN
gra-392	81	8	0.166	0.166	NUM
gra-392	81	9	-0.199	-0.199	PUNCT
gra-392	81	10	haemoglobin	haemoglobin	PROPN
gra-392	81	11	0.157	0.157	NUM
gra-392	81	12	-0.203	-0.203	NUM
gra-392	81	13	fasting	fast	VERB
gra-392	81	14	blood	blood	NOUN
gra-392	81	15	sugar	sugar	NOUN
gra-392	81	16	0.040	0.040	NUM
gra-392	81	17	[	[	X
gra-392	81	18	s	s	X
gra-392	81	19	]	]	X
gra-392	81	20	-0.397	-0.397	ADJ
gra-392	81	21	blood	blood	NOUN
gra-392	81	22	urea	urea	VERB
gra-392	81	23	0.366	0.366	NUM
gra-392	81	24	0.131	0.131	NUM
gra-392	81	25	serum	serum	NOUN
gra-392	81	26	cretinine	cretinine	PROPN
gra-392	81	27	0.749	0.749	NUM
gra-392	81	28	-0.046	-0.046	PUNCT
gra-392	81	29	gfr	gfr	PROPN
gra-392	81	30	0.904	0.904	NUM
gra-392	81	31	0.018	0.018	NUM
gra-392	81	32	number	number	NOUN
gra-392	81	33	of	of	ADP
gra-392	81	34	dialysis	dialysis	NOUN
gra-392	81	35	0.394	0.394	NUM
gra-392	81	36	-0.122	-0.122	PUNCT
gra-392	81	37	serum	serum	NOUN
gra-392	81	38	albumin	albumin	NOUN
gra-392	81	39	0.908	0.908	NUM
gra-392	81	40	0.017	0.017	NUM
gra-392	81	41	hdl	hdl	PROPN
gra-392	81	42	0.245	0.245	NUM
gra-392	81	43	0.167	0.167	NUM
gra-392	81	44	triglycerides	triglyceride	NOUN
gra-392	81	45	0.029	0.029	NUM
gra-392	81	46	[	[	X
gra-392	81	47	s	s	X
gra-392	81	48	]	]	X
gra-392	81	49	-0.310	-0.310	X
gra-392	81	50	total	total	ADJ
gra-392	81	51	cholesterol	cholesterol	NOUN
gra-392	81	52	0.079	0.079	NUM
gra-392	81	53	-0.250	-0.250	NUM
gra-392	81	54	mean	mean	VERB
gra-392	81	55	cimt	cimt	NOUN
gra-392	81	56	0.001	0.001	NUM
gra-392	82	1	[	[	X
gra-392	82	2	s	s	X
gra-392	82	3	]	]	X
gra-392	82	4	-0.536	-0.536	NOUN
gra-392	82	5	x	x	SYM
gra-392	82	6	113gjra	113gjra	PROPN
gra-392	82	7	global	global	ADJ
gra-392	82	8	journal	journal	NOUN
gra-392	82	9	for	for	ADP
gra-392	82	10	research	research	NOUN
gra-392	82	11	analysis	analysis	NOUN
gra-392	82	12	reported	report	VERB
gra-392	82	13	a	a	DET
gra-392	82	14	positive	positive	ADJ
gra-392	82	15	signicant	signicant	ADJ
gra-392	82	16	correlation	correlation	NOUN
gra-392	82	17	between	between	ADP
gra-392	82	18	serum	serum	NOUN
gra-392	82	19	magnesium	magnesium	NOUN
gra-392	82	20	levels	level	NOUN
gra-392	82	21	and	and	CCONJ
gra-392	82	22	serum	serum	VERB
gra-392	82	23	total	total	ADJ
gra-392	82	24	cholesterol	cholesterol	NOUN
gra-392	82	25	,	,	PUNCT
gra-392	82	26	and	and	CCONJ
gra-392	82	27	serum	serum	NOUN
gra-392	82	28	triglycerides	triglyceride	NOUN
gra-392	82	29	.	.	PUNCT
gra-392	83	1	conclusion	conclusion	NOUN
gra-392	83	2	:	:	PUNCT
gra-392	83	3	magnesium	magnesium	NOUN
gra-392	83	4	may	may	AUX
gra-392	83	5	affect	affect	VERB
gra-392	83	6	the	the	DET
gra-392	83	7	metabolism	metabolism	NOUN
gra-392	83	8	of	of	ADP
gra-392	83	9	tg	tg	PROPN
gra-392	83	10	and	and	CCONJ
gra-392	83	11	hdl	hdl	PROPN
gra-392	83	12	in	in	ADP
gra-392	83	13	liver	liver	NOUN
gra-392	83	14	and	and	CCONJ
gra-392	83	15	kidneys	kidney	NOUN
gra-392	83	16	,	,	PUNCT
gra-392	83	17	and	and	CCONJ
gra-392	83	18	it	it	PRON
gra-392	83	19	may	may	AUX
gra-392	83	20	be	be	AUX
gra-392	83	21	involved	involve	VERB
gra-392	83	22	in	in	ADP
gra-392	83	23	enzymes	enzyme	NOUN
gra-392	83	24	responsible	responsible	ADJ
gra-392	83	25	for	for	ADP
gra-392	83	26	lipoprotein	lipoprotein	ADJ
gra-392	83	27	synthesis	synthesis	NOUN
gra-392	83	28	,	,	PUNCT
gra-392	83	29	but	but	CCONJ
gra-392	83	30	these	these	DET
gra-392	83	31	factors	factor	NOUN
gra-392	83	32	are	be	AUX
gra-392	83	33	not	not	PART
gra-392	83	34	clearly	clearly	ADV
gra-392	83	35	understood	understand	VERB
gra-392	83	36	and	and	CCONJ
gra-392	83	37	further	further	ADJ
gra-392	83	38	large	large	ADJ
gra-392	83	39	studies	study	NOUN
gra-392	83	40	are	be	AUX
gra-392	83	41	needed	need	VERB
gra-392	83	42	in	in	ADP
gra-392	83	43	this	this	DET
gra-392	83	44	regard	regard	NOUN
gra-392	83	45	.	.	PUNCT
gra-392	84	1	our	our	PRON
gra-392	84	2	results	result	NOUN
gra-392	84	3	indicate	indicate	VERB
gra-392	84	4	that	that	SCONJ
gra-392	84	5	patients	patient	NOUN
gra-392	84	6	with	with	ADP
gra-392	84	7	ckd	ckd	PROPN
gra-392	84	8	undergoing	undergo	VERB
gra-392	84	9	mhd	mhd	NOUN
gra-392	84	10	show	show	NOUN
gra-392	84	11	signicant	signicant	ADJ
gra-392	84	12	dyslipidemia	dyslipidemia	NOUN
gra-392	84	13	.	.	PUNCT
gra-392	85	1	as	as	ADP
gra-392	85	2	a	a	DET
gra-392	85	3	rst	rst	PROPN
gra-392	85	4	means	means	NOUN
gra-392	85	5	of	of	ADP
gra-392	85	6	controlling	control	VERB
gra-392	85	7	hyperlipidemia	hyperlipidemia	NOUN
gra-392	85	8	,	,	PUNCT
gra-392	85	9	body	body	NOUN
gra-392	85	10	weight	weight	NOUN
gra-392	85	11	normalization	normalization	NOUN
gra-392	85	12	,	,	PUNCT
gra-392	85	13	dietary	dietary	ADJ
gra-392	85	14	modication	modication	NOUN
gra-392	85	15	,	,	PUNCT
gra-392	85	16	regular	regular	ADJ
gra-392	85	17	exercise	exercise	NOUN
gra-392	85	18	and	and	CCONJ
gra-392	85	19	education	education	NOUN
gra-392	85	20	about	about	ADP
gra-392	85	21	diet	diet	NOUN
gra-392	85	22	should	should	AUX
gra-392	85	23	be	be	AUX
gra-392	85	24	applied	apply	VERB
gra-392	85	25	.	.	PUNCT
gra-392	86	1	the	the	DET
gra-392	86	2	association	association	NOUN
gra-392	86	3	of	of	ADP
gra-392	86	4	dyslipidemia	dyslipidemia	NOUN
gra-392	86	5	with	with	ADP
gra-392	86	6	serum	serum	NOUN
gra-392	86	7	mg	mg	PROPN
gra-392	86	8	levels	level	NOUN
gra-392	86	9	is	be	AUX
gra-392	86	10	not	not	PART
gra-392	86	11	clearly	clearly	ADV
gra-392	86	12	understood	understand	VERB
gra-392	86	13	,	,	PUNCT
gra-392	86	14	and	and	CCONJ
gra-392	86	15	further	further	ADJ
gra-392	86	16	large	large	ADJ
gra-392	86	17	clinical	clinical	ADJ
gra-392	86	18	studies	study	NOUN
gra-392	86	19	are	be	AUX
gra-392	86	20	needed	need	VERB
gra-392	86	21	to	to	PART
gra-392	86	22	understand	understand	VERB
gra-392	86	23	this	this	DET
gra-392	86	24	association	association	NOUN
gra-392	86	25	better	well	ADV
gra-392	86	26	.	.	PUNCT
gra-392	87	1	references	reference	NOUN
gra-392	87	2	:	:	PUNCT
gra-392	88	1	1	1	X
gra-392	88	2	.	.	X
gra-392	89	1	pennell	pennell	PROPN
gra-392	89	2	p	p	X
gra-392	89	3	,	,	PUNCT
gra-392	89	4	leclercq	leclercq	NOUN
gra-392	89	5	b	b	NOUN
gra-392	89	6	,	,	PUNCT
gra-392	89	7	delahunty	delahunty	PROPN
gra-392	89	8	mi	mi	PROPN
gra-392	89	9	,	,	PUNCT
gra-392	89	10	walton	walton	PROPN
gra-392	89	11	ba	ba	PROPN
gra-392	89	12	.	.	PUNCT
gra-392	90	1	the	the	DET
gra-392	90	2	utility	utility	NOUN
gra-392	90	3	of	of	ADP
gra-392	90	4	non	non	ADJ
gra-392	90	5	-	-	ADJ
gra-392	90	6	hdl	hdl	ADJ
gra-392	90	7	in	in	ADP
gra-392	90	8	managing	manage	VERB
gra-392	90	9	dyslipidemia	dyslipidemia	NOUN
gra-392	90	10	of	of	ADP
gra-392	90	11	stage	stage	NOUN
gra-392	90	12	5	5	NUM
gra-392	90	13	chronic	chronic	ADJ
gra-392	90	14	kidney	kidney	NOUN
gra-392	90	15	diseases	disease	NOUN
gra-392	90	16	.	.	PUNCT
gra-392	91	1	clin	clin	PROPN
gra-392	91	2	nephrol	nephrol	PROPN
gra-392	91	3	2006;66(5):336.47	2006;66(5):336.47	NOUN
gra-392	91	4	.	.	PROPN
gra-392	91	5	2	2	NUM
gra-392	91	6	.	.	X
gra-392	91	7	soubassi	soubassi	ADJ
gra-392	91	8	lp	lp	PROPN
gra-392	91	9	,	,	PUNCT
gra-392	91	10	papadakis	papadakis	PROPN
gra-392	91	11	ed	ed	NOUN
gra-392	91	12	,	,	PUNCT
gra-392	91	13	theodoropoutos	theodoropoutos	ADJ
gra-392	91	14	ix	ix	ADV
gra-392	91	15	,	,	PUNCT
gra-392	91	16	et	et	PROPN
gra-392	91	17	al	al	PROPN
gra-392	91	18	.	.	PROPN
gra-392	91	19	incidence	incidence	NOUN
gra-392	91	20	and	and	CCONJ
gra-392	91	21	risk	risk	NOUN
gra-392	91	22	factors	factor	NOUN
gra-392	91	23	of	of	ADP
gra-392	91	24	coronary	coronary	ADJ
gra-392	91	25	artery	artery	NOUN
gra-392	91	26	disease	disease	NOUN
gra-392	91	27	in	in	ADP
gra-392	91	28	patients	patient	NOUN
gra-392	91	29	on	on	ADP
gra-392	91	30	chronic	chronic	ADJ
gra-392	91	31	hemodialysis	hemodialysis	NOUN
gra-392	91	32	.	.	PUNCT
gra-392	92	1	int	int	NOUN
gra-392	92	2	artif	artif	NOUN
gra-392	92	3	organs	organ	VERB
gra-392	92	4	2007;30(3):253	2007;30(3):253	NUM
gra-392	92	5	-	-	SYM
gra-392	92	6	7	7	NUM
gra-392	92	7	.	.	NOUN
gra-392	92	8	3	3	NUM
gra-392	92	9	.	.	X
gra-392	92	10	al	al	PROPN
gra-392	92	11	wake&15	wake&15	PROPN
gra-392	92	12	,	,	PUNCT
gra-392	92	13	mitvralli	mitvralli	NOUN
gra-392	92	14	ah	ah	INTJ
gra-392	92	15	,	,	PUNCT
gra-392	92	16	al	al	PROPN
gra-392	92	17	mohaya	mohaya	PROPN
gra-392	92	18	5	5	NUM
gra-392	92	19	,	,	PUNCT
gra-392	92	20	et	et	PROPN
gra-392	92	21	al	al	PROPN
gra-392	92	22	.	.	PROPN
gra-392	92	23	morbidity	morbidity	NOUN
gra-392	92	24	and	and	CCONJ
gra-392	92	25	mortality	mortality	NOUN
gra-392	92	26	in	in	ADP
gra-392	92	27	esrd	esrd	PROPN
gra-392	92	28	patients	patient	NOUN
gra-392	92	29	on	on	ADP
gra-392	92	30	dialysis	dialysis	NOUN
gra-392	92	31	.	.	PUNCT
gra-392	93	1	saudi	saudi	PROPN
gra-392	93	2	j	j	PROPN
gra-392	93	3	kidney	kidney	NOUN
gra-392	93	4	dis	dis	INTJ
gra-392	94	1	i	i	PRON
gra-392	94	2	ramp	ramp	VERB
gra-392	94	3	'	'	PUNCT
gra-392	94	4	2002;13	2002;13	NUM
gra-392	94	5	(	(	PUNCT
gra-392	94	6	4):473	4):473	NUM
gra-392	94	7	-	-	SYM
gra-392	94	8	7	7	NUM
gra-392	94	9	.	.	NOUN
gra-392	94	10	4	4	NUM
gra-392	94	11	.	.	X
gra-392	94	12	manske	manske	PROPN
gra-392	94	13	ci	ci	PROPN
gra-392	94	14	..	..	PROPN
gra-392	94	15	icasiske	icasiske	PROPN
gra-392	94	16	bt	bt	PROPN
gra-392	94	17	.	.	PROPN
gra-392	94	18	lipid	lipid	ADJ
gra-392	94	19	abnormalities	abnormality	NOUN
gra-392	94	20	after	after	ADP
gra-392	94	21	renal	renal	ADJ
gra-392	94	22	transplantation	transplantation	NOUN
gra-392	94	23	.	.	PUNCT
gra-392	95	1	in	in	ADP
gra-392	95	2	:	:	PUNCT
gra-392	95	3	keane	keane	PROPN
gra-392	95	4	wi	wi	PROPN
gra-392	95	5	,	,	PUNCT
gra-392	95	6	stein	stein	PROPN
gra-392	95	7	111	111	NUM
gra-392	95	8	,	,	PUNCT
gra-392	95	9	eds	ed	NOUN
gra-392	95	10	.	.	PUNCT
gra-392	96	1	lipids	lipids	ADJ
gra-392	96	2	and	and	CCONJ
gra-392	96	3	renal	renal	ADJ
gra-392	96	4	disease	disease	NOUN
gra-392	96	5	.	.	PUNCT
gra-392	97	1	contemporary	contemporary	ADJ
gra-392	97	2	issues	issue	NOUN
gra-392	97	3	in	in	ADP
gra-392	97	4	nephrology	nephrology	NOUN
gra-392	97	5	,	,	PUNCT
gra-392	97	6	churchill	churchill	PROPN
gra-392	97	7	livingstone	livingstone	PROPN
gra-392	97	8	,	,	PUNCT
gra-392	97	9	new	new	PROPN
gra-392	97	10	york	york	PROPN
gra-392	97	11	,	,	PUNCT
gra-392	97	12	1991;3/-61	1991;3/-61	NUM
gra-392	97	13	.	.	NOUN
gra-392	97	14	5	5	NUM
gra-392	97	15	.	.	X
gra-392	97	16	keane	keane	PROPN
gra-392	97	17	wp	wp	PROPN
gra-392	97	18	,	,	PUNCT
gra-392	97	19	oda	oda	PROPN
gra-392	97	20	h.	h.	PROPN
gra-392	97	21	lipid	lipid	PROPN
gra-392	97	22	abnormalities	abnormality	NOUN
gra-392	97	23	in	in	ADP
gra-392	97	24	end	end	NOUN
gra-392	97	25	stage	stage	NOUN
gra-392	97	26	renal	renal	ADJ
gra-392	97	27	disease	disease	NOUN
gra-392	97	28	nephrol	nephrol	NOUN
gra-392	97	29	dial	dial	NOUN
gra-392	97	30	transplant	transplant	NOUN
gra-392	97	31	1998;13(suppl	1998;13(suppl	PROPN
gra-392	97	32	1):4s-9	1):4s-9	PROPN
gra-392	97	33	.	.	PUNCT
gra-392	98	1	6	6	NUM
gra-392	98	2	.	.	X
gra-392	99	1	kronenherg	kronenherg	PROPN
gra-392	99	2	f	f	PROPN
gra-392	99	3	,	,	PUNCT
gra-392	99	4	kathrein	kathrein	ADJ
gra-392	99	5	h	h	NOUN
gra-392	99	6	,	,	PUNCT
gra-392	99	7	ko	ko	PROPN
gra-392	99	8	-	-	PROPN
gra-392	99	9	nig	nig	PROPN
gra-392	99	10	p	p	NOUN
gra-392	99	11	,	,	PUNCT
gra-392	99	12	et	et	PROPN
gra-392	99	13	al	al	PROPN
gra-392	99	14	.	.	PUNCT
gra-392	100	1	apolipoprotein(a	apolipoprotein(a	PROPN
gra-392	100	2	)	)	PUNCT
gra-392	100	3	•	•	NOUN
gra-392	100	4	phenotypes	phenotype	NOUN
gra-392	100	5	predict	predict	VERB
gra-392	100	6	the	the	DET
gra-392	100	7	risk	risk	NOUN
gra-392	100	8	for	for	ADP
gra-392	100	9	carotid	carotid	NOUN
gra-392	100	10	a	a	DET
gra-392	100	11	inerostierosis	inerostierosis	NOUN
gra-392	100	12	in	in	ADP
gra-392	100	13	patients	patient	NOUN
gra-392	100	14	with	with	ADP
gra-392	100	15	end	end	NOUN
gra-392	100	16	-	-	PUNCT
gra-392	100	17	stage	stage	NOUN
gra-392	100	18	renal	renal	ADJ
gra-392	100	19	disease	disease	NOUN
gra-392	100	20	.	.	PUNCT
gra-392	101	1	arteriosder	arteriosder	PROPN
gra-392	101	2	thromb	thromb	NOUN
gra-392	101	3	1994	1994	NUM
gra-392	101	4	;	;	PUNCT
gra-392	101	5	14	14	NUM
gra-392	101	6	:	:	SYM
gra-392	101	7	1405	1405	NUM
gra-392	101	8	-	-	SYM
gra-392	101	9	11	11	NUM
gra-392	101	10	.	.	PUNCT
gra-392	102	1	7	7	X
gra-392	102	2	.	.	X
gra-392	102	3	mountokalakis	mountokalakis	PROPN
gra-392	102	4	rd	rd	PROPN
gra-392	102	5	.	.	PUNCT
gra-392	102	6	magnesium	magnesium	NOUN
gra-392	102	7	metabolism	metabolism	NOUN
gra-392	102	8	in	in	ADP
gra-392	102	9	chronic	chronic	ADJ
gra-392	102	10	renal	renal	ADJ
gra-392	102	11	failure	failure	NOUN
gra-392	102	12	.	.	PUNCT
gra-392	103	1	magnessres	magnessre	NOUN
gra-392	103	2	1990;3(2	1990;3(2	NUM
gra-392	103	3	):	):	PUNCT
gra-392	103	4	121	121	NUM
gra-392	103	5	-	-	SYM
gra-392	103	6	7	7	NUM
gra-392	103	7	.	.	NOUN
gra-392	103	8	8	8	NUM
gra-392	103	9	.	.	PUNCT
gra-392	103	10	lindeman	lindeman	PROPN
gra-392	103	11	rd	rd	PROPN
gra-392	103	12	.	.	PUNCT
gra-392	103	13	chronic	chronic	ADJ
gra-392	103	14	renal	renal	ADJ
gra-392	103	15	failure	failure	NOUN
gra-392	103	16	and	and	CCONJ
gra-392	103	17	magnesium	magnesium	NOUN
gra-392	103	18	metabolism	metabolism	NOUN
gra-392	103	19	.	.	PUNCT
gra-392	104	1	magnesium	magnesium	NOUN
gra-392	104	2	1986;5(5	1986;5(5	NUM
gra-392	104	3	-	-	SYM
gra-392	104	4	6	6	NUM
gra-392	104	5	):	):	PUNCT
gra-392	104	6	293	293	NUM
gra-392	104	7	-	-	SYM
gra-392	104	8	300	300	NUM
gra-392	104	9	.	.	PUNCT
gra-392	104	10	9	9	NUM
gra-392	104	11	.	.	PUNCT
gra-392	105	1	j.	j.	PROPN
gra-392	105	2	elementol	elementol	PROPN
gra-392	105	3	.	.	PUNCT
gra-392	105	4	,et	,et	PUNCT
gra-392	106	1	al	al	PROPN
gra-392	106	2	evaluation	evaluation	NOUN
gra-392	106	3	of	of	ADP
gra-392	106	4	the	the	DET
gra-392	106	5	correlations	correlation	NOUN
gra-392	106	6	between	between	ADP
gra-392	106	7	magnesium	magnesium	NOUN
gra-392	106	8	concentration	concentration	NOUN
gra-392	106	9	and	and	CCONJ
gra-392	106	10	selected	select	VERB
gra-392	106	11	serum	serum	NOUN
gra-392	106	12	lipid	lipid	NOUN
gra-392	106	13	components	component	NOUN
gra-392	106	14	in	in	ADP
gra-392	106	15	women	woman	NOUN
gra-392	106	16	and	and	CCONJ
gra-392	106	17	men	man	NOUN
gra-392	106	18	of	of	ADP
gra-392	106	19	different	different	ADJ
gra-392	106	20	age	age	NOUN
gra-392	106	21	with	with	ADP
gra-392	106	22	chronic	chronic	ADJ
gra-392	106	23	kidney	kidney	NOUN
gra-392	106	24	failure2030,15(2	failure2030,15(2	NOUN
gra-392	106	25	):	):	PUNCT
gra-392	106	26	321	321	NUM
gra-392	106	27	-	-	SYM
gra-392	106	28	329	329	NUM
gra-392	106	29	.	.	PUNCT
gra-392	106	30	10	10	NUM
gra-392	106	31	.	.	PUNCT
gra-392	107	1	nasir	nasir	PROPN
gra-392	107	2	h	h	PROPN
gra-392	107	3	,	,	PUNCT
gra-392	107	4	baradaran	baradaran	NOUN
gra-392	107	5	a.	a.	NOUN
gra-392	107	6	correlation	correlation	NOUN
gra-392	107	7	of	of	ADP
gra-392	107	8	swum	swum	ADJ
gra-392	107	9	magnesium	magnesium	NOUN
gra-392	107	10	with	with	ADP
gra-392	107	11	dyslipidemia	dyslipidemia	NOUN
gra-392	107	12	in	in	ADP
gra-392	107	13	maintenance	maintenance	NOUN
gra-392	107	14	hrunodialysis	hrunodialysis	NOUN
gra-392	107	15	patients	patient	NOUN
gra-392	107	16	.	.	PUNCT
gra-392	108	1	acta	acta	PROPN
gra-392	108	2	medics	medics	PROPN
gra-392	108	3	2004	2004	NUM
gra-392	108	4	;	;	PUNCT
gra-392	108	5	47	47	NUM
gra-392	108	6	:	:	SYM
gra-392	108	7	263	263	NUM
gra-392	108	8	-	-	SYM
gra-392	108	9	265	265	NUM
gra-392	108	10	.	.	PUNCT
gra-392	109	1	11	11	NUM
gra-392	109	2	.	.	PUNCT
gra-392	110	1	feng	feng	PROPN
gra-392	110	2	lill	lill	PROPN
gra-392	110	3	,	,	PUNCT
gra-392	110	4	xintian	xintian	ADJ
gra-392	110	5	zhanng	zhanng	PROPN
gra-392	110	6	et	et	PROPN
gra-392	110	7	al	al	PROPN
gra-392	110	8	.	.	PROPN
gra-392	110	9	corelataion	corelataion	NOUN
gra-392	110	10	of	of	ADP
gra-392	110	11	serum	serum	NOUN
gra-392	110	12	magnesium	magnesium	NOUN
gra-392	110	13	with	with	ADP
gra-392	110	14	cardiovascular	cardiovascular	ADJ
gra-392	110	15	risk	risk	NOUN
gra-392	110	16	factors	factor	NOUN
gra-392	110	17	in	in	ADP
gra-392	110	18	maintenance	maintenance	NOUN
gra-392	110	19	hernodialysis	hernodialysis	NOUN
gra-392	110	20	patients	patient	NOUN
gra-392	110	21	.	.	PUNCT
gra-392	111	1	a	a	DET
gra-392	111	2	cross	cross	ADJ
gra-392	111	3	sectional	sectional	ADJ
gra-392	111	4	study	study	NOUN
gra-392	111	5	.	.	PUNCT
gra-392	112	1	magnes	magnes	PROPN
gra-392	112	2	res	re	VERB
gra-392	112	3	2013	2013	NUM
gra-392	112	4	july	july	PROPN
gra-392	112	5	-	-	PUNCT
gra-392	112	6	sep	sep	PROPN
gra-392	112	7	;	;	PUNCT
gra-392	112	8	26(3	26(3	NUM
gra-392	112	9	)	)	PUNCT
gra-392	112	10	;	;	PUNCT
gra-392	112	11	100	100	NUM
gra-392	112	12	-	-	SYM
gra-392	112	13	8	8	NUM
gra-392	112	14	12	12	NUM
gra-392	112	15	.	.	PUNCT
gra-392	113	1	anson	anson	PROPN
gra-392	113	2	mr	mr	PROPN
gra-392	113	3	.	.	PROPN
gra-392	113	4	,	,	PUNCT
gra-392	113	5	tvlaheshwad	tvlaheshwad	PROPN
gra-392	113	6	net	net	PROPN
gra-392	113	7	al	al	PROPN
gra-392	113	8	:	:	PUNCT
gra-392	113	9	correlation	correlation	NOUN
gra-392	113	10	or	or	CCONJ
gra-392	113	11	serum	serum	NOUN
gra-392	113	12	magnesium	magnesium	NOUN
gra-392	113	13	with	with	ADP
gra-392	113	14	dyslipidemia	dyslipidemia	NOUN
gra-392	113	15	in	in	ADP
gra-392	113	16	patients	patient	NOUN
gra-392	113	17	on	on	ADP
gra-392	113	18	maintenance	maintenance	NOUN
gra-392	113	19	iie•odiaiys;s	iie•odiaiys;s	NUM
gra-392	113	20	saudi	saudi	ADJ
gra-392	113	21	j	j	PROPN
gra-392	113	22	kidney	kidney	PROPN
gra-392	113	23	dis	dis	PROPN
gra-392	113	24	transplant	transplant	NOUN
gra-392	113	25	.	.	PUNCT
gra-392	114	1	2012	2012	NUM
gra-392	114	2	jan;23(1):21	jan;23(1):21	PROPN
gra-392	114	3	-	-	PUNCT
gra-392	114	4	5	5	NUM
gra-392	114	5	.	.	NOUN
gra-392	114	6	13	13	NUM
gra-392	114	7	.	.	PUNCT
gra-392	115	1	rebles	reble	NOUN
gra-392	115	2	escola	escola	PROPN
gra-392	115	3	1	1	NUM
gra-392	115	4	m	m	PROPN
gra-392	115	5	,	,	PUNCT
gra-392	115	6	aibarran	aibarran	PROPN
gra-392	115	7	1	1	NUM
gra-392	115	8	,	,	PUNCT
gra-392	115	9	espada	espada	PROPN
gra-392	115	10	r	r	PROPN
gra-392	115	11	,	,	PUNCT
gra-392	115	12	cruz	cruz	PROPN
gra-392	115	13	a.	a.	NOUN
gra-392	115	14	correlation	correlation	NOUN
gra-392	115	15	of	of	ADP
gra-392	115	16	serum	serum	NOUN
gra-392	115	17	magnesium	magnesium	NOUN
gra-392	115	18	and	and	CCONJ
gra-392	115	19	serum	serum	NOUN
gra-392	115	20	lipid	lipid	NOUN
gra-392	115	21	levels	level	NOUN
gra-392	115	22	in	in	ADP
gra-392	115	23	hemodialysis	hemodialysis	NOUN
gra-392	115	24	patients	patient	NOUN
gra-392	115	25	.	.	PUNCT
gra-392	116	1	dialysis	dialysis	NOUN
gra-392	116	2	&	&	CCONJ
gra-392	116	3	transplantation	transplantation	NOUN
gra-392	116	4	1998	1998	NUM
gra-392	116	5	,	,	PUNCT
gra-392	116	6	volum	volum	NOUN
gra-392	116	7	27,10	27,10	NUM
gra-392	116	8	:	:	PUNCT
gra-392	116	9	644.648	644.648	NUM
gra-392	116	10	oct	oct	NOUN
gra-392	116	11	.	.	PROPN
gra-392	116	12	volume-8	volume-8	NUM
gra-392	116	13	,	,	PUNCT
gra-392	116	14	issue-10	issue-10	NOUN
gra-392	116	15	,	,	PUNCT
gra-392	116	16	october-2019	october-2019	ADJ
gra-392	116	17	•	•	NUM
gra-392	116	18	print	print	NOUN
gra-392	116	19	issn	issn	PROPN
gra-392	116	20	no	no	NOUN
gra-392	116	21	.	.	PROPN
gra-392	116	22	2277	2277	NUM
gra-392	116	23	8160	8160	NUM
gra-392	116	24	•	•	NOUN
gra-392	116	25	doi	doi	NOUN
gra-392	116	26	:	:	PUNCT
gra-392	116	27	10.36106	10.36106	NUM
gra-392	116	28	/	/	SYM
gra-392	116	29	gjra	gjra	NOUN
gra-392	116	30	114	114	NUM
gra-392	116	31	x	x	NOUN
gra-392	116	32	gjra	gjra	ADJ
gra-392	116	33	global	global	ADJ
gra-392	116	34	journal	journal	PROPN
gra-392	116	35	for	for	ADP
gra-392	116	36	research	research	NOUN
gra-392	116	37	analysis	analysis	NOUN